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Abstract 11 
Zbtb11 is a conserved transcription factor mutated in families with hereditary intellectual disability. Its 12 
precise molecular and cellular functions are currently unknown, precluding our understanding of the 13 
aetiology of this disease. Using a combination of functional genomics, genetic and biochemical 14 
approaches here we show that Zbtb11 plays essential roles in maintaining the homeostasis of 15 
mitochondrial function. Mechanistically, we find Zbtb11 facilitates the recruitment of Nuclear 16 
Respiratory Factor 2 (NRF-2) to its target promoters, activating a subset of nuclear genes with roles in 17 
the biogenesis of respiratory complex I and the mitoribosome. Genetic inactivation of Zbtb11 resulted 18 
in a severe complex I assembly defect, impaired mitochondrial respiration, mitochondrial 19 
depolarisation, and ultimately proliferation arrest and cell death. Experimental modelling of the 20 
pathogenic human mutations showed these have a destabilising effect on the protein, resulting in 21 
reduced Zbtb11 dosage, down-regulation of its target genes, and impaired complex I biogenesis. Our 22 
study establishes Zbtb11 as an essential mitochondrial regulator, improves our understanding of the 23 
transcriptional mechanisms of nuclear control over mitochondria, and may help understand the 24 
aetiology of Zbtb11-associated intellectual disability. 25 
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Introduction 26 
The biochemical energy contained within nutrients is captured through the process of cellular 27 
respiration, which culminates in the production of ATP through oxidative phosphorylation (OXPHOS) 28 
in mitochondria 1. OXPHOS is fuelled by a chain of redox reactions in which electrons are transferred 29 
along an electron transport chain (ETC) comprised of 4 complexes (I-IV) localised to the mitochondrial 30 
inner membrane 2. Three of the ETC complexes (I, III and IV) couple substrate oxidation with proton 31 
extrusion from the mitochondrial matrix into the intermembrane space, thus creating an 32 
electrochemical gradient across the mitochondrial inner membrane which forces protons back into the 33 
matrix mainly through complex V (ATP synthase), driving the synthesis of ATP 3. Tissues with high 34 
energy demands, such as brain and muscle, are particularly reliant on the activity of the ETC, and these 35 
are usually disproportionally affected in mitochondrial diseases. Nevertheless, because the activity of 36 
the ETC is also vital for regenerating the cellular pool of redox cofactors that catalyse a number of 37 
other metabolic reactions 4,5, a functioning ETC is essential for all proliferating cells, irrespective of 38 
their ATP consumption 6. 39 
Mitochondria possess their own genome (mtDNA) and transcription machinery, as well as a specialised 40 
organellar ribosome (the mitoribosome). While the mtDNA encodes a small number of core subunits 41 
of the OXPHOS complexes, the majority of the mitochondrial proteome is encoded in the nuclear 42 
genome (nDNA). Mitochondrial biogenesis and function are therefore controlled to a significant extent 43 
through transcriptional regulation of nuclear genes. A number or transcription factors have been 44 
implicated in the regulation of nuclear-encoded mitochondrial genes, some of which are essential while 45 
others have modulatory roles important mainly in specific cell types or in conditions of increased 46 
energy demand 7,8. The nuclear respiratory factors (NRFs) NRF-1 and NRF-2 (also known as GABP) 47 
are essential transcriptional activators, and the most prominent regulators of nuclear-encoded 48 
mitochondrial genes, driving the expression of the majority of nuclear-encoded OXPHOS subunits, 49 
mitoribosomal proteins, as well as mtDNA replication and transcription factors 9. NRF-1 and NRF-50 
2/GABP play overlapping but non-redundant roles in activating these genes, and they are found 51 
associated with different DNA sequence motifs. It is not currently completely understood how the 52 
activity of NRFs is regulated, how their recruitment to target genes is controlled, or whether they 53 
engage all their genomic targets in the same way or through locus-specific mechanisms. 54 
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Zinc finger and BTB domain-containing (ZBTB) proteins are a family of structurally related 55 
transcription factors, which function by binding DNA through C-terminal zinc finger motifs and 56 
recruiting co-factors via protein-protein interactions mediated by an N-terminal BTB domain 10. 57 
Zbtb11 is a poorly characterised ubiquitously expressed ZBTB protein that is conserved in vertebrates. 58 
Recent genetic studies of consanguineous families with recessive intellectual disability (ID) identified 59 
homozygous missense mutations in human ZBTB11 as causal variants 11,12. Two pathogenic mutations 60 
were identified, both of which are predicted to disrupt individual Zbtb11 zinc finger motifs. Affected 61 
patients display morphological defects in the brain, including ventriculomegaly and cerebellar atrophy, 62 
and also show neuromuscular defects such as ataxia and facial hypotonia 12. The molecular and cellular 63 
functions of Zbtb11 have hitherto remained unknown, so the aetiology of this disease is not currently 64 
understood. Zbtb11 is listed as a housekeeping protein by the Human Protein Atlas 13 65 
(https://www.proteinatlas.org/humanproteome/tissue/housekeeping), and two separate genome-wide 66 
genetic screens (gene trap and CRISPR) recently conducted in (several/different) human cell lines 14,15 67 
(KBM7, HAP1 and K562) have identified ZBTB11 as an essential gene, indicating that this factor plays 68 
fundamental cellular roles. Consistent with this (notion), all ZBTB11 mutations reported so far have 69 
been missense mutations that are not predicted to cause complete loss of function, suggesting the 70 
disease may be the result of a partial impairment of otherwise essential functions carried out by Zbtb11. 71 
However, what these functions might be has remained unknown. 72 
Here we investigate the cellular and molecular functions of Zbtb11 and find that it is a key regulator 73 
of mitochondrial function. We show that Zbtb11 controls the locus-specific recruitment of NRF-74 
2/GABP, but not NRF-1, to activate a subset of nuclear-encoded genes with roles in the biogenesis of 75 
OXPHOS complex I and the mitoribosome. Genetic inactivation of Zbtb11 leads to a severe complex 76 
I assembly defect and loss of complex I activity, reduced respiration, mitochondrial depolarisation, and 77 
consequently to proliferation arrest and cell death. Zbtb11 therefore cooperates with NRF-2/GABP to 78 
maintain the homeostasis of mitochondrial function. We provide evidence that mutations associated 79 
with hereditary intellectual disability disrupt this function by destabilising the Zbtb11 protein, leading 80 
to its reduced dosage, down-regulation of its target genes and impaired complex I biogenesis. Our study 81 
establishes Zbtb11 as an essential regulator of mitochondrial function, reveals a previously 82 
unanticipated mechanism of locus-specific regulation of NRF-2/GABP activity, and indicates that 83 
intellectual disability associated with mutations in ZBTB11 may be at least in part the manifestation of 84 
a mitochondrial disease.  85 
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Results 86 
Zbtb11 targets nuclear-encoded mitochondrial genes  87 
We initially set out to determine the potential functions of Zbtb11 by identifying the exact locations 88 
where it binds in the genome, and to this end we carried out chromatin immunoprecipitation coupled 89 
with high-throughput sequencing (ChIP-seq) experiments. Due to lack of existing validated anti-90 
Zbtb11 antibodies, we used CRISPR/Cas9 to ‘knock-in’ a 3xFLAG tag into the Zbtb11 locus of the 91 
E14 mouse ESC line 16 (Fig. 1a), and isolated a homozygous line in which all endogenous Zbtb11 92 
protein is N-terminally tagged with 3xFLAG (FLAG-Zbtb11) (Fig. 1b and Supplementary Fig.1a). We 93 
then performed anti-FLAG ChIP-seq in Zbtb11FLAG/FLAG E14 cells and control E14 WT cells, 94 
identifying 9,350 FLAG-Zbtb11 consensus peaks from 3 biological replicates (Irreproducibility 95 
Discovery Rate (IDR) < 0.02, see Methods), from which we removed 219 peaks that that were also 96 
identified by FLAG ChIP-seq in control E14 WT cells. 97 
We used this reliable set of FLAG-Zbtb11 binding sites to validate an anti-Zbtb11 antibody which, 98 
although not suitable for immunoblotting, reproducibly showed strong ChIP enrichment at the same 99 
sites as FLAG-Zbtb11 (Supplementary Fig.1b). ChIP-seq with this Zbtb11 antibody in E14 WT cells 100 
detected 8,957 Zbtb11 peaks (IDR < 0.02), of which 7,500 overlapped with the FLAG-Zbtb11 peaks 101 
in Zbtb11FLAG/FLAG E14 cells (Fig. 1c). The ChIP-seq signal was very well correlated between Zbtb11 102 
and FLAG-Zbtb11 data sets (Fig. 1d and Supplementary Fig.1c-e). We therefore generated a high-103 
confidence Zbtb11 peak set comprised of the 7,500 peaks common to both Zbtb11 and FLAG-Zbtb11, 104 
which we subsequently used in the rest of the analyses in this study.  105 
We found Zbtb11 binds predominantly (56%) at gene promoters, the vast majority (85.6 %) of which 106 
are CpG island promoters (Fig. 1e) - a promoter type mainly associated with ubiquitously expressed 107 
housekeeping genes 17,18. Analysing the distribution of Zbtb11 peak signal values revealed that the top 108 
858 peaks are significantly stronger than the rest of the peaks in the data set, to the extent that they are 109 
outliers in the distribution (values are higher than 1.5 times the inter-quartile range over the third 110 
quartile) (Supplementary Fig.1f). These Zbtb11-high peaks represent the top 10% of the peak set, and 111 
their signal is overall 8.7 times stronger than the rest of the peaks. Zbtb11-high peaks show increased 112 
association with promoters compared to the entire Zbtb11 peak data set (86.2% vs 56%) (Fig. 1e).  113 
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To identify pathways and cellular processes potentially controlled by Zbtb11, we carried out functional 114 
enrichment analyses using genes with the most prominent Zbtb11 binding sites (the 858 Zbtb11-high 115 
peaks). The most highly enriched annotation term cluster was related to mitochondria (13-fold 116 
enrichment), 15% of tested genes being included in this category (Fig. 1f). This was followed at some 117 
distance by ribosome and translation (7.8-fold enrichment), however 52% of genes in this category 118 
function in mitochondrial translation and were also listed in the mitochondria annotation cluster. We 119 
did not detect any enrichment of terms related to development or ESC differentiation. Zbtb11 therefore 120 
seems to mainly associate with promoters of a subset of housekeeping genes, among which genes with 121 
mitochondrial functions are highly enriched.  122 
To determine whether the genomic distribution of Zbtb11 is conserved between cell types, we 123 
performed ChIP-seq with Zbtb11 antibodies in a pure population of FACS-sorted mouse thymocytes, 124 
as well as in the human cell line HEK293. The strength of Zbtb11 ChIP-seq peaks in mouse thymocytes 125 
and human HEK293 cells showed a very similar distribution to mESC, revealing a select group of 126 
Zbtb11-high peaks (Supplementary Fig. 1f). The binding of Zbtb11 to its target promoters was 127 
remarkably well conserved across cell types and species, showing a high degree of conservation not 128 
only in the location of binding sites but also in affinity. 87% of Zbtb11-high peaks identified in mESCs 129 
were conserved in thymocytes, and 53% were conserved in human cells (Fig. 1g). Zbtb11 showed a 130 
significant preference for conserved binding sites, ChIP-seq peaks at these sites being considerably 131 
stronger than the cell type- and species-specific ones (Fig. 1g). Moreover, among conserved sites 132 
binding affinity was highly correlated between cell types (Pearson’s r = 0.85), and between species (r 133 
= 0.75) (Fig. 1h). Functional enrichment analysis of Zbtb11 target genes in human cells revealed that 134 
just as in mice these are also highly enriched in genes with mitochondrial function (Supplementary Fig. 135 
1g).  136 
Altogether, the genomic distribution of Zbtb11 is consistent with a conserved essential role of this 137 
factor in regulating a subset of housekeeping genes, in particular genes with mitochondrial function.  138 
Zbtb11 is essential for proliferation and cell viability 139 
To establish an experimental system that would allow us to interrogate the functions of Zbtb11 we first 140 
attempted to generate constitutive Zbtb11 KO ESCs by targeting exon 3 using CRISPR/Cas9-mediated 141 
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genome editing. However, although we were able to efficiently isolate and expand heterozygous 142 
WT/KO clones, we were never able to isolate homozygous Zbtb11 KO lines, which suggested that just 143 
as in human cells 14,15 Zbtb11 is also essential for cell viability in mouse ESCs. We therefore took a 144 
different approach, generating an inducible Zbtb11 KO ESC line. Using CRISPR/Cas9-mediated 145 
‘knock-in’, we flanked exon 3 of Zbtb11 with loxP sites, and also inserted the ERt2-Cre transgene 19 146 
in the Rosa26 (R26) locus 20 (Fig. 2a and Supplementary Fig.2a). In these cells ERt2-Cre can be 147 
induced by addition of 4-hydroxytamoxifen (4OHT) to delete Zbtb11 exon 3, which is predicted to 148 
induce a frame shift and truncate the Zbtb11 protein to an 185 amino acid N-terminal fragment that 149 
lacks the BTB domain and all of the zinc fingers motifs.  150 
Treatment of Zbtb11lox/lox R26ERt2-Cre cells with 4OHT, but not with the carrier ethanol (EtOH), resulted 151 
in efficient deletion of Zbtb11 exon 3 and depletion of functional Zbtb11 mRNA transcripts, which 152 
was essentially complete 24 hours after 4OHT treatment (Fig. 2b). ChIP-qPCR experiments with anti-153 
Zbtb11 antibodies showed the signal was decreased 24 hours after treatment and became virtually 154 
undetectable from 48 hours post-treatment onwards (Fig. 2b and Supplementary Fig.2b). This further 155 
validated the specificity of the anti-Zbtb11 ChIP antibody, and showed that Zbtb11 is completely 156 
depleted at the protein level 48 hours after Zbtb11 KO is induced. Acute depletion of Zbtb11 transcripts 157 
and protein is maintained at 72 and 96 hours post-KO induction (Fig. 2b), indicating there is no 158 
selection for cells that may escape deletion and have a growth advantage. These results establish our 159 
inducible KO cell line as a robust experimental system that allows rapid and acute depletion of Zbtb11 160 
to study its cellular functions. 161 
Zbtb11lox/lox R26ERt2-Cre cells treated with EtOH continued to grow exponentially as long as they were 162 
regularly passaged. By contrast, the proliferation of 4OHT-treated cells slowed down after Zbtb11 was 163 
completely depleted from the chromatin, being completely arrested 96 hours after treatment (Fig. 2b). 164 
Cell cycle analyses by flow cytometry revealed that Zbtb11 depletion resulted in a reduction of cells 165 
in S-phase and a relative increase of cells in G1, while the proportion of cells in G2/M did not appear 166 
to change (Fig. 2c). This indicates that the slow-down in proliferation caused by Zbtb11 depletion is 167 
mainly underpinned by cell cycle arrest in G1. Concomitant with proliferation arrest, cell death was 168 
also noticeable in 4OHT-treated cultures starting at day 4 (96h), becoming extensive a day later (120h) 169 
so that very few cells were left in culture beyond 5 days post-treatment (Fig. 2d). Flow cytometry 170 
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measurements of cleaved Caspase-3 failed to detect any increase in apoptosis rates (Supplementary 171 
Fig.2c). However, the increase in cell death was measurable by Annexin V-mediated detection of 172 
phosphatidylserine externalisation (Fig. 2e and Supplementary Fig.2d), which was significant from 96 173 
hours post-4OHT treatment onwards. No significant changes in proliferation or cell death were 174 
discernible in 4OHT-treated Zbtb11wt/wt R26wt cells (Fig. 2c and 2e), confirming that the observed 175 
effects were not artefacts of 4OHT treatment. These results establish that Zbtb11 is essential for 176 
proliferation and cell viability, and when its functions are blocked cells undergo cell cycle arrest in G1 177 
and subsequently suffer Caspase-independent cell death. 178 
Zbtb11 functions as a transcriptional activator  179 
To determine what processes are disrupted by the depletion of Zbtb11, we carried out whole 180 
transcriptome analyses by directional RNA-sequencing (RNA-seq). We compared Zbtb11lox/lox R26ERt2-181 
Cre cells treated with either 4OHT (Zbtb11 KO) or EtOH (control). To control for non-specific effects 182 
of 4OHT we also analysed Zbtb11wt/wt R26wt cells treated with 4OHT. We analysed cells treated for 48 183 
hours because at this time point Zbtb11 protein is completely depleted in 4OHT-treated cells (see Fig. 184 
2b and Supplementary Fig.2b), but there are no detectable changes in proliferation and cell survival 185 
(see Fig. 2c and 2e). We therefore expected to detect mainly transcriptional changes at genes directly 186 
regulated by Zbtb11.  187 
When comparing 4OHT- and EtOH-treated Zbtb11lox/lox R26ERt2-Cre cells, we found 154 differentially 188 
expressed (DE) genes (FDR < 0.05), 145 of which were down-regulated (Fig. 3a and Supplementary 189 
Data), which indicates that Zbtb11 functions as a transcriptional activator. None of these genes were 190 
DE when comparing 4OHT-treated Zbtb11wt/wt R26wt cells with EtOH-treated cells, indicating that their 191 
deregulation was not a result of the 4OHT treatment. To verify our RNA-seq results through a different 192 
method, we performed qRT-PCR for a panel of 20 genes spanning the entire range of effect sizes, and 193 
the results of the two methods were strongly correlated (Supplementary Fig. 3a). 194 
To verify that the transcriptional changes are specific to Zbtb11 depletion, we performed experiments 195 
in which we rescued the expression of Zbtb11 in KO cells by ectopically expressing its cDNA. We 196 
transfected Zbtb11lox/lox R26ERt2-Cre cells with a plasmid expressing either FLAG-Zbtb11–IRES–GFP, 197 
or GFP alone as control, and treated them for 48 hours with either EtOH or 4OHT. We subsequently 198 
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FACS-sorted GFP-positive cells to isolate successfully transfected cells, confirmed specific expression 199 
of the FLAG-Zbtb11 protein by immunoblotting (Fig. 3b), and subsequently performed qRT-PCR to 200 
measure the expression of a panel of genes found to be down-regulated in the RNA-seq dataset. As 201 
seen in Fig. 3b, the expression of these genes was specifically rescued in the 4OHT-treated cells 202 
transfected with FLAG-Zbtb11 but not in 4OHT-treated cells transfected with GFP only. These results 203 
confirm the specificity of our inducible Zbtb11 KO ESC line and show that the transcriptional changes 204 
detected by RNA-seq are indeed the result of Zbtb11 depletion.  205 
Integration of the RNA-seq and ChIP-seq datasets revealed that 147 of the 154 DE genes (95%) have 206 
Zbtb11 peaks at their promoters, and that these binding sites are the strongest in the data set 207 
(Supplementary Fig. 3b). Moreover, Zbtb11 binding at the promoters of DE genes is remarkably well 208 
conserved across cell types and mammalian species, these binding sites being also the strongest in 209 
mouse thymocytes and human HEK293 cells (Fig. 3c). These results firmly indicate that Zbtb11 is 210 
directly regulating these genes, and that strength of binding is a good indicator of whether a Zbtb11 211 
binding event is critical for transcriptional regulation. 212 
In agreement with the results of the ChIP-seq analyses showing that Zbtb11 targets housekeeping 213 
genes, the Zbtb11-dependent genes were constitutively expressed at levels that were very well 214 
correlated between mouse ESCs, thymocytes and HEK293 cells (Supplementary Fig. 3c). To determine 215 
which processes are controlled by Zbtb11, we performed functional enrichment analyses using the list 216 
of DE genes. This identified only one significant cluster of annotation terms (FDR < 0.05), which is 217 
defined by mitochondria and had an enrichment score of 6.12 (Fig. 3d and Supplementary Table 1). 218 
To investigate more thoroughly the association between Zbtb11 and genes with mitochondrial 219 
functions, we cross-referenced the DE genes with the MitoMiner database 21, and found that 27% 220 
encode proteins with mitochondrial function, which represents an enrichment of 4.5 relative to the 221 
genes tested. All DE genes were nuclear-encoded, and they did not include any of the factors previously 222 
implicated in the regulation mitochondrial biogenesis and function, such as NRF-1, NRF-2/GABP, or 223 
members of the PGC-1, PPAR, or ERR families. 224 
Finally, to verify that the changes observed at the mRNA level are reflected at the protein level, we 225 
carried out immunoblots on whole cell lysates from Zbtb11lox/lox R26ERt2-Cre and Zbtb11wt/wt R26wt cells 226 
treated with either EtOH or 4OHT for 48 and 72 hours. As seen in Fig. 3e, the mitochondrial proteins 227 
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Mrpl48 and Ndufc2, encoded by DE genes, were already strongly down-regulated 48 hours post-228 
treatment. These changes were not detected in 4OHT-treated Zbtb11wt/wt R26wt cells, indicating they 229 
are not caused by 4OHT treatment alone. Altogether these results show that Zbtb11 has fundamental 230 
housekeeping roles in directly promoting the expression of a subset of nuclear-encoded mitochondrial 231 
proteins. 232 
Zbtb11 controls recruitment of NRF-2 to its target promoters 233 
To understand how Zbtb11 controls its target genes, we sought to identify other factors that Zbtb11 234 
might functionally interact with. To this end we performed de novo motif discovery using the Zbtb11 235 
ChIP-seq peakset, and separately the promoter sequences of the 154 Zbtb11-dependent genes. Both 236 
mouse and human ChIP-seq datasets identified as the top hit an identical motif, which closely matched 237 
that recognised by the ETS-domain protein GABPa (Fig. 4a and Supplementary Fig. 4a). In addition, 238 
the most highly enriched motif at the promoters of the Zbtb11-dependent genes was the same GABPa 239 
motif, in both the mouse and the human genome, and this was firmly centred around the transcription 240 
start sites (TSS) (Fig. 4b). The consensus motif for Nuclear Respiratory Factor 1 (NRF-1) binding was 241 
also found to be enriched at the promoters of DE genes, but to a lesser extent and without a clear 242 
preference for the TSS (Fig. 4b). GABPa is the DNA binding subunit of the multimeric transcription 243 
factor GABP (GA-Binding Protein) also known as Nuclear Respiratory Factor 2 (NRF-2), which 244 
alongside NRF-1 plays essential roles in regulating mitochondrial biogenesis and function. Our motif 245 
analyses therefore suggested that Zbtb11 may regulate its target genes and mitochondrial activity 246 
through functional interactions with NRF-1 and/or NRF-2/GABP.  247 
To test whether these motif analyses were corroborated by experimental evidence, we integrated our 248 
Zbtb11 ChIP-seq data with previously published ChIP-seq datasets for GABPa 22 and NRF-1 23 in 249 
mouse ESCs. This revealed significant genome-wide overlap between Zbtb11 and GABPa peaks (p-250 
value < 2.2e-16), but not between Zbtb11 and NRF-1 peaks (Fig. 4c). 63% of Zbtb11 peaks overlap 251 
with GABPa, but this fraction increases to 97% among Zbtb11-high peaks. While Zbtb11 overlaps 252 
with NRF-1 mainly at sites that are also occupied by GABPa, there is extensive NRF-1-independent 253 
overlap between Zbtb11 and GABPa. In agreement with previous studies showing that NRF-1 and 254 
NRF-2 share some common target genes, we find significant genome-wide overlap between NRF-1 255 
and GABPa peaks, including at many Zbtb11-independent sites (Fig. 4c). Illustrative of the different 256 
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locus-specific associations between Zbtb11, NRF-2 and NRF-1, these factors co-occupy the promoters 257 
of some mitoribosome subunit genes, but Zbtb11 does not bind or regulate classical NRF-1 and NRF-258 
2 targets such as the promoters of cytochrome c, mitochondrial transcription factors TFB or cytochrome 259 
c oxidase subunit genes (Supplementary Fig. 4b and c). At the promoters of DE genes, virtually all 260 
(98%) Zbtb11 peaks are also bound by GABPa, but only half of them are bound by NRF-1.  261 
Analysing the strength of binding at shared sites, we found strong positive correlation genome-wide 262 
between Zbtb11 and GABPa (r = 0.63, p-value = 2.516e-16), with the peaks at DE genes 263 
overwhelmingly showing strong affinity for both Zbtb11 and GABPa (Fig. 4d, left panel). By contrast, 264 
we found no correlation between Zbtb11 and NRF-1 ChIP-seq signal (r = 0.04, p-value = 0.012) either 265 
genome-wide or at DE genes (Fig. 4d, right panel). 266 
A promoter-centric analysis focusing on the ChIP-seq signal across the 1kb region around the TSS of 267 
all genes expressed in mouse ESCs (n = 14,362), revealed a positive correlation between Zbtb11 and 268 
GABPa (r = 0.49) and between GABPa and NRF-1 (r = 0.34), but not between Zbtb11 and NRF-1 (r 269 
= 0.10) (Fig. 4e, left panel). When considering only the promoters of the DE genes, Zbtb11 is very 270 
strongly correlated with GABPa (r = 0.74), but only weakly correlated with NRF-1 (r = 0.27) (Fig. 4e, 271 
right panel). Our analyses therefore strongly indicate that Zbtb11 functionally interacts with NRF-2, 272 
but do not support an interaction between Zbtb11 and NRF-1.    273 
The strong positive correlation between Zbtb11 and GABPa binding suggested that these factors may 274 
bind cooperatively at their shared targets. Alternatively, Zbtb11 and GABPa could bind independently 275 
to the same genomic sites, which could take place on the same or on different alleles in the cell 276 
population, their positive correlation potentially being driven by their ability to recognise the same 277 
DNA binding motif. To distinguish between these possibilities, we performed sequential ChIP (ChIP-278 
reChIP) with antibodies to Zbtb11 and GABPa. As seen in Fig. 4f, chromatin fragments bound by 279 
Zbtb11 are also strongly bound by GABPa, showing that Zbtb11 and GABPa bind simultaneously to 280 
their shared genomic sites. To explore the potential cooperative binding of these factors, we performed 281 
GABPa and NRF-1 ChIP in control and Zbtb11 KO cells. This revealed that Zbtb11 depletion strongly 282 
impairs GABPa recruitment to shared Zbtb11/GABPa sites, but not to Zbtb11-independent sites (Fig. 283 
4g). By comparison, NRF-1 recruitment was not affected by Zbtb11 depletion, either at shared 284 
Zbtb11/NRF-1 sites or at Zbtb11-independent sites (Fig. 4g). Zbtb11 therefore specifically controls the 285 
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locus-specific recruitment of NRF-2 to its target promoters. Although Zbtb11 also shares some target 286 
genes with NRF-1, their association with these promoters appears to take place through independent 287 
mechanisms.  288 
Altogether our results strongly indicated that Zbtb11 cooperates with NRF-2 to regulate mitochondrial 289 
function. 290 
Zbtb11 depletion impairs mitochondrial respiration 291 
To test whether mitochondrial function is affected in Zbtb11 KO cells, we first investigated the status 292 
of the mitochondrial membrane potential (MMP) by staining live cells with TMRE 293 
(tetramethylrhodamine, ethyl ester), a cationic fluorophore that permeates the plasma membrane and 294 
accumulates in the mitochondrial matrix in MMP-dependent manner. As can be seen in Fig. 5a (left 295 
panel) the TMRE staining decreased progressively after Zbtb11 depletion. This was not the result of 296 
fewer mitochondria, as the ratio of mitochondrial to nuclear DNA was the same in control and Zbtb11 297 
KO cells (Supplementary Fig. 5a). These results indicate that mitochondria gradually depolarise in 298 
Zbtb11 KO cells, and show that Zbtb11 is required for the maintenance of functional mitochondria but 299 
not for mitochondrial replication. 300 
To test the ability of Zbtb11 KO cells to maintain their MMP in more stressful circumstances than the 301 
resting state, e.g. in situations when ATP demands suddenly increase, we challenged them with 302 
increasing concentrations of the mitochondrial uncoupler FCCP (Carbonyl cyanide 4-303 
(trifluoromethoxy)phenylhydrazone). FCCP allows protons to flow back into the mitochondrial matrix, 304 
short-circuiting the MMP and stimulating the ETC complexes, which respond by increasing their 305 
activity to restore the cross-membrane proton gradient 24. We stained control and Zbtb11 KO cells with 306 
TMRE in the presence of increasing concentrations of FCCP and subsequently analysed them by flow 307 
cytometry. As seen in Fig. 5a (right panel) and Supplementary Fig. 4b (left panel), the MMP in Zbtb11 308 
KO cells showed increased sensitivity to FCCP, which gradually intensified following Zbtb11 309 
depletion. These effects were not observed in Zbtb11wt/wt R26wt cells treated with 4OHT 310 
(Supplementary Fig. 5b, right panel). 311 
The inability of Zbtb11 KO cells to maintain polarised mitochondria could be caused either by 312 
decreased respiration or by an increase in proton leak or ATP demand. To determine whether 313 
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respiration is impaired in Zbtb11-deficient cells, we used the Seahorse platform to measure oxygen 314 
consumption rates (OCR), which in combination with sequential addition of specific mitochondrial 315 
inhibitors (oligomycin, FCCP and a mixture of rotenone and antimycin A) allows the derivation of 316 
several mitochondrial respiration parameters, as previously described 24 (see Methods). This revealed 317 
that respiration is already significantly impaired 48 hours post-KO induction, and it further deteriorates 318 
24 hours later (72 hours post-KO induction) (Fig. 5b). Basal respiration was the most affected, both its 319 
constituent parameters (leak respiration and ATP synthesis) showing the largest decrease of all 320 
parameters measured, which shows that mitochondrial depolarisation in Zbtb11 KO cells is caused by 321 
deficiencies in the ETC and not by increased proton leak or ATP turnover. The coupling efficiency 322 
between respiration and ATP synthesis did not change in Zbtb11 KO cells at any of the time points 323 
assessed, which indicates that Zbtb11 depletion has no direct effect on the proton leak, and that the 324 
reduction in leak respiration is just a consequence of a reduced proton flux through the system. The 325 
maximal respiratory capacity was also decreased in Zbtb11 KO cells –although less affected than basal 326 
respiration to begin with, it subsequently deteriorated significantly, in agreement with the observed 327 
increasing sensitivity of the MMP to the uncoupling agent FCCP (see Fig. 5a, right panel).  328 
Altogether these results show that Zbtb11 KO cells have a deficient OXPHOS system, which fails to 329 
maintain the MMP and thus to supply an adequate proton-motive force, both at resting state and when 330 
forced to function at maximum capacity. Importantly, the decline of mitochondrial functions in our 331 
experimental system closely followed the down-regulation of Zbtb11-dependent mitochondrial 332 
proteins, but preceded any overt signs of cell death or cell cycle arrest. 333 
Zbtb11 controls complex I biogenesis  334 
To determine more specifically how Zbtb11 depletion affects mitochondrial respiration, we performed 335 
pathway mapping and over-representation analysis using the list of Zbtb11-dependent genes with 336 
known or predicted mitochondrial functions. This identified ‘complex I biogenesis’ and ‘mitochondrial 337 
translation’ as the most likely affected processes (FDR < 0.05, Fig. 6a and Table S3). There were four 338 
genes involved in the biogenesis of respiratory complex I, encoding one core subunit (Ndufs7), two 339 
accessory subunits (Ndufa12 and Ndufc2), and one assembly factor (Ndufaf1) (Fig. 6a and Table S3). 340 
There were eight DE genes involved in mitochondrial translation, all of which encode subunits of the 341 
mitochondrial ribosome (Fig. 6a and Table S3). All DE genes that mapped to mitochondrial pathways 342 
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were down-regulated, and the effect size was particularly pronounced at Ndufc2 and Ndufaf1 (5.5- and 343 
4-fold, respectively, see Fig. 6a). This acute depletion was also reflected at the protein level, as Ndufc2 344 
was virtually undetectable by immunoblotting 72 hours after Zbtb11 KO induction (see Fig. 3e). These 345 
results suggested that Zbtb11 KO cells may be defective in the synthesis and assembly of respiratory 346 
complex I. In addition, these cells may also have a compromised mitoribosome, which would cause a 347 
general defect in mitochondrial translation, and therefore have a knock-on effect on the synthesis of all 348 
OXPHOS complexes with mtDNA-encoded subunits (I, III, IV and V).  349 
To assess the integrity of respiratory complexes in Zbtb11 KO cells we carried out immunoblotting 350 
with antibodies against specific subunits that become degraded when their respective OXPHOS 351 
complex is unstable or fails to assemble 25–27. We found a striking down-regulation of complex I 352 
integrity marker Ndufb8 (Fig. 6b), despite the fact its transcript is expressed at normal level (fold-353 
change 1.006, adjusted p-value = 0.99). This indicated that the down-regulation of the complex I 354 
subunits Ndufc2, Ndufaf1, Ndufa12 and Ndufs7, resulting from Zbtb11 depletion, was enough to 355 
disrupt the biogenesis of complex I, which in turn lead to the degradation of the stability marker 356 
Ndufb8. The integrity markers for complex III (Uqcrc2) and complex IV (Mtco1) were also down-357 
regulated, but to a lesser extent and only after prolonged Zbtb11 depletion (Fig. 6b). By comparison, 358 
the expression of complex II and V markers remained unchanged at all times (Fig. 6b). These results 359 
indicated complex I biogenesis is specifically affected in the immediate aftermath of Zbtb11 depletion, 360 
in agreement with the prediction by the differential gene expression analysis.  361 
Further immunoblotting experiments showed that not all complex I subunits are degraded (Fig. 6c), 362 
indicative of an assembly defect rather than degradation of the entire holocomplex, which would be 363 
consistent with the strong down-regulation of the accessory subunit Ndufc2 and assembly factor 364 
Ndufaf1. To assess this, we separated mitochondrial extracts by blue native polyacrylamide gel 365 
electrophoresis (BN-PAGE) and subsequently performed immunoblotting with antibodies against 366 
Ndufb11 - a subunit that is not degraded as a result of Zbtb11 depletion (Fig. 6c). This showed that 48 367 
hours post-Zbtb11 KO induction the holocomplex was already reduced, while a smaller Ndufb11-368 
containing subcomplex was increased, consistent with an assembly defect (Fig. 6d). Subsequently, the 369 
amount of complex I holocomplex continued to decrease, and at 96 hours both the holocomplex and 370 
the subcomplex were barely detectable with Ndufb11 antibodies (Fig. 6d), indicating the subcomplex 371 
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also becomes unstable or fails to assemble. Altogether, these data show that Zbtb11 depletion leads to 372 
a severe complex I assembly defect.  373 
Consistent with this biogenesis defect, spectrophotometric quantification of complex I activity in 374 
mitochondrial extracts (see Methods) revealed this was gradually lost in Zbtb11 KO cells (Fig. 6e), 375 
strongly indicating that the reduction in mitochondrial respiration that follows Zbtb11 depletion (see 376 
Fig. 5b) is underpinned to a significant extent by complex I insufficiency. The impairment of complex 377 
I activity also provides a potential explanation for the proliferation arrest in Zbtb11 KO cells. NADH 378 
oxidation by complex I maintains the cellular pool of NAD+ which functions as an electron acceptor 379 
in several biosynthetic pathways required for cellular growth and proliferation 4,5. A critical 380 
consequence of ETC disruption and NAD+ depletion is aspartate insufficiency, which becomes 381 
restrictive for proliferation 4,5. Consistent with aspartate insufficiency taking place in Zbtb11 KO cells, 382 
cell cycle and proliferation arrest only become evident (Fig. 2b and c) once complex I activity 383 
deteriorates significantly 96 hours post-KO induction (Fig. 6e). Proliferation arrest induced by 384 
aspartate insufficiency can be rescued in several somatic cell lines by supplementing the media with 385 
either aspartate directly, or pyruvate as surrogate electron acceptor 4,5; however, it is not yet known 386 
whether this is also the case in ESCs. To investigate this, we cultured control and Zbtb11 KO cells in 387 
either standard ESC media, or with supraphysiological levels of pyruvate or aspartate (see Methods). 388 
In the immediate aftermath of Zbtb11 depletion, when Zbtb11 KO cells in standard media are still able 389 
to proliferate, supplementation of the media did not have a significant effect on cellular proliferation 390 
(Figure 6f, upper panel). However, at 96 hours post-KO induction when complex I activity is 391 
dramatically reduced, Zbtb11-deficient cells can only keep proliferating if pyruvate or aspartate is 392 
added to the media (Figure 6f, lower panel). These results indicate that aspartate insufficiency caused 393 
by disruption of complex I is an important contributor to proliferation arrest in Zbtb11 KO cells.  394 
Finally, to understand whether the impaired biogenesis of respiratory complexes in Zbtb11 KO cells is 395 
underpinned by a mitoribosome defect, we first tested if pharmacological inhibition of the 396 
mitoribosome mimics the respiratory complexes defect that follows Zbtb11 depletion. Blocking 397 
mitochondrial translation with chloramphenicol in otherwise untreated Zbtb11lox/lox R26ERt2-Cre cells 398 
resulted in complete depletion of complexes I, III and IV within 48 hours of treatment, while complexes 399 
II and V remained unaffected (Fig. 7a). This shows that mitochondria-encoded subunits of complexes 400 
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I, III and IV are rapidly turned over, leading to the collapse of these complexes 48 hours after their 401 
synthesis is blocked. This phenotype is largely recapitulated in 120 hours Zbtb11 KO cells (Fig. 6b and 402 
Supplementary Fig. 6), when a milder down-regulation of complexes III and IV is also apparent, 403 
despite the fact that Zbtb11 does not control the expression of any of their subunits, therefore 404 
suggesting that mitochondrial translation may become impaired 72 hours post-Zbtb11 KO induction. 405 
To test this possibility, we compared the dynamics of mitoribosome-dependent synthesis of respiratory 406 
complexes in control and Zbtb11 KO cells. We first depleted complexes I, III and IV by treating cells 407 
with chloramphenicol for 48 hours, after which we removed the mitochondrial translation block, 408 
allowing it to resume, and subsequently monitored the regeneration of the respiratory complexes (Fig. 409 
7b). By synchronising the chloramphenicol and EtOH/4OHT treatments in Zbtb11lox/lox R26ERt2-Cre cells, 410 
we allowed mitochondrial translation to resume either 48 or 72 hours post-Zbtb11 KO induction (Fig. 411 
7b). Upon release from the mitochondrial translation block, control cells resumed synthesis of 412 
mitochondria-encoded proteins and regenerated all respiratory complexes within 48 hours (Fig. 7c). 413 
By contrast, in Zbtb11 KO cells complex I biogenesis was completely blocked and never recovered 414 
after chloramphenicol removal, while synthesis of complex III and IV was partly impaired but not fully 415 
arrested (Fig. 7c). These results are consistent with a partial impairment of mitochondrial translation 416 
leading to reduced complex III and IV synthesis, but which in the case of complex I is compounded or 417 
fully masked by the specific and more severe biogenesis defect caused by the down-regulation of 418 
complex I subunits directly controlled by Zbtb11 (see Supplementary Table 2). 419 
In conclusion, Zbtb11 specifically controls complex I biogenesis by promoting the expression of key 420 
accessory and assembly subunits, while also exerting – albeit to a lesser extent – broader control over 421 
the synthesis of respiratory complexes, likely through its role in mitoribosome biogenesis. 422 
Pathogenic mutations destabilise the Zbtb11 protein 423 
In order to investigate the relevance of our findings to the aetiology of ZBTB11-associated intellectual 424 
disability, we modelled the mutations associated with this disease in our experimental system. Two 425 
ZBTB11 missense mutations have been identified in families with hereditary intellectual disability, 426 
both of which lead to single amino acid substitutions of key histidine residues (H729Y and H880Q) 12 427 
in C2H2 zinc finger motifs that are conserved between mouse and humans. We induced Zbtb11 KO 428 
and rescued its expression by ectopically expressing either wild type or mutant FLAG-Zbtb11 cDNA 429 
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(H729Y or H880Q). The cDNA was linked to an IRES-GFP reporter, which allowed us to use flow 430 
cytometry to sort successfully transfected cells with the same level of cDNA expression. As seen in 431 
Fig. 8a, although the wild type and the two mutant FLAG-Zbtb11 cDNA were expressed at comparable 432 
levels, only wild type Zbtb11 was able to fully rescue the expression of complex I and mitoribosome 433 
biogenesis genes. Complex I biogenesis genes Ndufc2 and Ndufaf1 were particularly affected by the 434 
Zbtb11 mutations, their transcripts being downregulated 2-fold when Zbtb11 expression was rescued 435 
with H880Q and H729Y mutants, respectively. By comparison, the maximum effect size among the 436 
mitoribosome genes was 1.6-fold down-regulation as a result of mutating Zbtb11.  437 
Immunoblotting with antibodies to the complex I stability marker Ndufb8, showed that the inability of 438 
mutant Zbtb11 to fully support transcription of complex I biogenesis genes results in reduced amounts 439 
of complex I (Fig. 8b). Surprisingly, immunoblotting with anti-FLAG antibodies revealed that mutant 440 
FLAG-Zbtb11 protein levels were also reduced approximately two-fold for both mutants (Fig. 8b), 441 
despite their respective cDNA transcripts being at least as abundant as wild type FLAG-Zbtb11 (Fig. 442 
8a). This shows that the pathogenic mutations in the zinc finger motifs of Zbtb11 cause the protein to 443 
be unstable or mark it for degradation.  444 
To frame our findings in the context of human tissue-specific gene expression, we integrated our results 445 
with the Genotype-Tissue Expression (GTEx) dataset (V8), which contains whole transcriptome data 446 
from 948 individuals across 52 different primary tissues. This revealed that while ZBTB11 is 447 
ubiquitously expressed, it is most highly expressed in samples from the cerebellum (Fig. 8c) – in 448 
agreement with an important function for Zbtb11 in this tissue, also indicated by the fact that patients 449 
with ZBTB11 mutations have cerebellar atrophy 12. Of the 154 Zbtb11-dependent genes we identified 450 
in mouse ES cells, 149 were successfully matched to human orthologues. Their expression was highly 451 
correlated with ZBTB11 (Fig. 8c), supporting the notion that the regulatory relationship of Zbtb11 with 452 
its target genes is conserved in mammals.  453 
Altogether, our results indicate that the effect of human ZBTB11 mutations is mediated at least in part 454 
by a reduction in the amount of Zbtb11 protein available to activate its target genes. This is likely to 455 
be particularly detrimental in tissues requiring higher Zbtb11 expression, such as the cerebellum, and 456 
may be further compounded by a defect in the ability of mutant Zbtb11 to recognise its cognate targets 457 
through the zinc finger motifs. Importantly, these mutations impair complex I biogenesis, indicating 458 
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that the phenotype in affected patients may be, at least partly, the manifestation of a mitochondrial 459 
disease. This is supported by the phenotypical overlap with other mitochondrial diseases, which are 460 
also commonly characterised by cerebellar atrophy, ataxia and hypotonia 28. 461 
Discussion 462 
There are currently approximately 700 genes known to be involved in the genetics of intellectual 463 
disability (ID) 29, but it is estimated the total number may be greater than 2,500 30. Large-scale studies 464 
of consanguineous families with inherited ID have identified new candidate loci, including several 465 
genes encoding proteins with unknown function 11,31. Determining the molecular and cellular functions 466 
of these proteins is a crucial step towards understanding the aetiology of the different forms of ID. 467 
Zbtb11 is a ubiquitously expressed transcription factor recently found to be mutated in two families 468 
with inherited ID 11,12, but which had remained largely uncharacterised. In this study we performed a 469 
systematic analysis of its cellular functions.  470 
Consistent with the findings of previous genome-wide genetic screens, we found Zbtb11 is an essential 471 
factor required for cell proliferation and survival, which explains why only missense mutations, but no 472 
homozygous loss of function variants, have been identified so far in ID patients or in the Genome 473 
Aggregation Database (gnomAD) 32. Using an inducible KO system allowed us to perform timed 474 
deletion experiments and detect the early transcriptional changes at genes under direct Zbtb11 control. 475 
Zbtb11 appears to function as a transcriptional activator, contrasting with the majority of previously 476 
characterised ZBTB proteins, most of which have been reported to function as transcriptional 477 
repressors 10.  478 
A recent study reported that in zebrafish, Zbtb11 directly regulates p53 by binding to its gene promoter 479 
and repressing transcription 33. Inspection of our ChIP-seq datasets also revealed binding of Zbtb11 at 480 
the promoter of p53 gene (Trp53), but Trp53 was not deregulated in our RNA-seq experiment (fold-481 
change = 0.93, adjusted p-value = 0.99) (Supplementary Fig. 7a). qRT-PCR analyses confirmed that 482 
Trp53 transcripts do not change in Zbtb11 KO cells, even after prolonged Zbtb11 depletion 72 hours 483 
post-KO induction (Supplementary Fig. 7b), leading us to conclude that Zbtb11 does not directly 484 
regulate the expression of p53 in mouse ESCs. The discrepancy between our results and the previous 485 
study may be due to species-specific differences. Alternatively, the zebrafish Zbtb11 missense mutation 486 
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found to upregulate p53 may act as a gain of function mutation that potentiates the transcriptional 487 
activating function of Zbtb11.  488 
We find instead that in mammalian cells Zbtb11 promotes the expression of a select group of house-489 
keeping genes that are significantly enriched in genes encoding mitochondrial proteins. Our data 490 
strongly indicate that its target genes and mechanisms of activation by Zbtb11 are conserved between 491 
cell types and across mammalian species. Promoting the expression of this subset of mitochondrial 492 
proteins has functional importance, as Zbtb11 depletion significantly impairs respiration and leads to 493 
mitochondrial depolarisation. These changes precede detectable increases in cell death, indicating they 494 
are not a consequence of apoptosis. Maintenance of mitochondrial function is therefore a key role of 495 
Zbtb11.  496 
Mechanistically, we show that Zbtb11 is an integral part of the network of nuclear transcription factors 497 
which controls mitochondrial activity and biogenesis, being responsible for the recruitment of NRF-498 
2/GABP to a subset of its target sites. Zbtb11 shares a large proportion of its genomic binding sites 499 
with NRF-2/GABP and our experiments established these two factors bind simultaneously at their 500 
common targets, where NRF-2/GABP recruitment is heavily dependent on Zbtb11. The association 501 
between Zbtb11 and NRF-2/GABP appears to be conserved in mammals, and importantly, it is a 502 
signature of virtually all Zbtb11-high sites and promoters of Zbtb11-dependent genes, indicating that 503 
recruitment of NRF-2/GABP is part of the mechanism through which Zbtb11 controls its targets genes. 504 
NRF-2/GABP is a potent promoter activator, as recently illustrated by the finding that in a large 505 
proportion of glioblastomas the telomerase gene is reactivated by promoter mutations that generate 506 
novel NRF-2/GABP binding sites 34. The transcriptional activating role of Zbtb11 can therefore be 507 
explained by its ability to facilitate the recruitment of NRF-2/GABP to promoters. 508 
Interestingly, despite their extensive genome-wide association, NRF-2/GABP also binds to a number 509 
of promoters, including some of its known classical targets, where its binding is not Zbtb11-dependent. 510 
This shows that NRF-2/GABP does not bind its targets through a uniform mechanism, but its 511 
recruitment is instead regulated in locus-specific manner. This may reflect the existence of locus-512 
specific complexes in which NRF-2/GABP associates with different factors. Alternatively, Zbtb11 may 513 
facilitate promoter activation by regulating the local chromatin structure to increase TSS accessibility 514 
for NRF-2/GABP. 515 
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Zbtb11 was found to co-localise with NRF-1 at the promoters of several genes, the majority of which, 516 
however, are also bound by NRF-2/GABP. At these sites Zbtb11 specifically controls the recruitment 517 
of NRF-2/GABP but not NRF-1, showing that although NRFs overlap extensively genome-wide, their 518 
activity can be distinctly regulated even at shared promoters. 519 
Zbtb11 controls the biogenesis of complex I by promoting the expression of nuclear-encoded complex 520 
I subunits with core (Ndufs7), accessory (Ndufc2 and Ndufa12) and assembly (Ndufaf1) roles, Ndufc2 521 
and Ndufaf1 being particularly sensitive to Zbtb11 depletion (see Supplementary Data). An abundance 522 
of evidence from studies of human disease 35–37 and in vitro experimental approaches 38 show that 523 
inactivating either one of these factors individually leads to severe defects in complex I assembly, so 524 
their combined down-regulation in Zbtb11 KO cells is expected to lead to the collapse of complex I – 525 
an outcome that is reflected in our results. Zbtb11 also directly controls the expression of 526 
mitoribosomal protein components, and its depletion eventually caused a broad defect in the biogenesis 527 
of respiratory complexes that partly recapitulates the pharmacological inhibition of mitochondrial 528 
translation. This effect, however, was not as pronounced as the specific impairment of complex I 529 
biogenesis, which may be due to the fact that the majority of the mitoribosome genes were not down-530 
regulated to the same extent as the complex I genes Ndufc2 and Ndufaf1.  531 
Zbtb11 therefore maintains the homeostasis of the OXPHOS system primarily by activating 532 
transcription at genes of nuclear-encoded complex I subunits, as well as by indirectly facilitating the 533 
expression of mitochondria-encoded subunits at the translational level. In its absence, the ETC is 534 
disrupted, leading to cell proliferation arrest. The mechanism by which ETC disruption leads to 535 
proliferation arrest even in cells with high glycolysis rates was recently revealed to be aspartate 536 
restriction caused by depletion of NAD+. A functional ETC, and complex I activity in particular, is 537 
required to maintain the pool of available NAD+ which functions as an essential cofactor in the process 538 
of aspartate synthesis in the mitochondrial matrix. In Zbtb11 KO cells the activity of complex I 539 
gradually decreases until it reaches a critical level that can no longer support proliferation and cells 540 
arrest in G1. The G1 arrest is consistent with a metabolic restriction that blocks entry into S-phase, in 541 
this case underpinned by aspartate depletion. This is evidenced by the fact that provision of aspartate 542 
is able to rescue proliferation specifically at the stage when Zbtb11-deficient cells first show signs of 543 
cell cycle arrest (96 hours post-KO induction) (see Fig. 6f). 544 
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Experimental modelling of the missense Zbtb11 mutations associated with ID showed that these have 545 
a destabilising effect on the Zbtb11 protein. Both mutations lead to the substitution of the second 546 
histidine residue in C2H2 zinc finger motifs, which is predicted to disrupt the folding of the motifs, 547 
and protein misfolding may accelerate its degradation. The overall effect of the mutations is therefore 548 
equivalent to a Zbtb11 knock-down, which could be further compounded by the fact that the mutant 549 
protein may be impaired in its ability to bind and activate target promoters. The complex I genes Ndufc2 550 
and Ndufaf1 were particularly sensitive to the reduced Zbtb11 dosage, and consequently, Zbtb11 551 
mutations lead to impaired complex I biogenesis. Our findings may help understand the aetiology of 552 
this form of ID, as neuronal development, survival and activity, are heavily reliant on mitochondria for 553 
ATP production and for regulation of calcium and redox signalling. Mitochondria play key roles in 554 
axonal specification and growth 39 as well as in synaptic plasticity 40, and their importance in neuronal 555 
development and survival is underlined by the fact that many mitochondrial disorders are characterised 556 
by neurological abnormalities. Of note, cerebellar atrophy and ataxia are prominent features in patients 557 
with mtDNA pathogenic mutations 28, and are also evident in patients with ZBTB11 mutations. 558 
Moreover, at least two genes that we find to be directly regulated by Zbtb11, NDUFA12 and 559 
NDUFAF1, are known to be mutated in mitochondrial diseases (Leigh Syndrome and 560 
cardioencephalomyopathy, respectively) 37,38. We therefore propose that at least some of the 561 
phenotypical features reported in patients with ZBTB11 mutations are manifestations of a 562 






Mouse ES cell line E14 (Doetschman et al. 1987) and its derivatives were maintained on plates pre-569 
coated with 0.2% gelatin (G1393, Sigma). Media was Knockout DMEM (10829018, Gibco), 570 
supplemented with foetal bovine serum (10%) (10270106, Thermo Fisher Scientific), non-essential 571 
amino acids (11140035, Gibco), glutamine (2mM), beta-mercaptoethanol, penicillin and streptomycin, 572 
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and LIF (ESG1106, Merck-Millipore). Proliferation of Zbtb11 KO cells was rescued by supplementing 573 
the media with 1mM pyruvate and 10mM aspartate. Proliferation rates were calculated as previously 574 
described 5 , doublings/day = log 2 (cell number assay day / cell number first day) / number of days in 575 
culture. 576 
CRISPR/Cas9-mediated genome editing  577 
Guide RNA (gRNA) sequences were synthesised as single stranded oligos (Sigma-Aldrich), annealed 578 
and cloned in the vectors PX458 (pSpCas9(BB)-2A-GFP, Addgene plasmid # 48138) or 579 
PX461(pSpCas9n(BB)-2A-GFP, Addgene plasmid # 48140), both a gift from Feng Zhang (Ran et al. 580 
2013). Recombinant plasmids were verified by Sanger sequencing and electroporated into E14 cells 581 
using the Nucleofector II platform (Lonza) (program A-013). 48 hours post-electroporation GFP-582 
expressing cells were FACS-sorted and cloned by serial dilution in 96-well plates. Single cell colonies 583 
were allowed to grow for a week and subsequently screened by PCR. Colonies detected as recombinant 584 
were further analysed by Sanger sequencing, by PCR amplifying the targeted locus, cloning the PCR 585 
amplicons in the pCR2.1 TOPO plasmid (Thermo Fisher Scientific) and transforming 10-beta 586 
competent E. coli bacteria (New England Biolabs). Plasmid inserts from 20 bacterial colonies were 587 
sequenced for each ES cell colony to verify homozygosity.  588 
Generation of the Zbtb11FLAG/FLAG E14 line  589 
The Zbtb11 ATG start codon was targeted using two gRNAs (GCCGGCGGCTATGTCAAGCG and 590 
CGCCTGTCAGTGGTAAGGAG) cloned in PX461, which co-expresses the Cas9 nickase and GFP. 591 
A donor template for homology-directed repair (HDR), that contained the modified ATG start site with 592 
the 3xFLAG tag flanked by two 800bp homologous arms, was also electroporated at the same time. 593 
Recombinant colonies were screened by PCR using the primers TGGGAGAAAGATGCTCTCCAT 594 
and CACCGTCATGGTCTTTGTAGTC. Primers TGGGAGAAAGATGCTCTCCAT and 595 
CCTCGCTTGACATAGCCGCC detect the wild type unmodified locus but not the Zbtb11FLAG allele.  596 
Generation of the inducible Zbtb11 KO line  597 
In the first step introns 2 and 3 were targeted using the gRNAs TAGGATTAAGGAAAACATTG and 598 
GCTTCTAATACTCTGTGCAA, respectively, cloned in PX458 which co-expresses the wild type 599 
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Cas9 nuclease and GFP. The plasmids encoding the two gRNAs were co-electroporated with a HDR 600 
template containing a 2.8kb region spanning Zbtb11 exon 3 and flanking intronic sequences modified 601 
to include the loxP sequence alongside ectopic restriction sites at the regions targeted by the gRNAs 602 
(see also Fig. 2a). Successfully targeted colonies were detected by PCR 603 
(GATAGGGAGCCCTGCTCTCA and CCACAGCCTCCAAGTCTTCC) followed by restriction 604 
digest with EcoRI and BamHI (see also Supplementary Fig.2a). Following the isolation of a 605 
homozygous Zbtb11lox/lox line, the ERt2-Cre transgene was inserted into the Rosa26 locus using the 606 
gRNA ACTCCAGTCTTTCTAGAAGA cloned into PX458, and the pMB80 plasmid (a gift from 607 
Tyler Jacks, Addgene plasmid # 12168) (McLaughlin et al. 2007) as HDR template. Recombinant 608 
colonies were detected by nested PCR with the primers GGCCCAAATGTTGCTGGATA and 609 
AGAGCCTCGGCTAGGTAGGG in the first step, and AGGTTCTGCGGGAAACCATT and 610 
AGGTAGGGGATCGGGACTCT in the second step. 611 
To induce deletion of Zbtb11 exon 3, cells were treated with 4-hydroxytamoxyfen (T176, Sigma-612 
Aldrich) by adding it to the media from a 1,000x stock dissolved in ethanol, to a final concentration of 613 
250nM.  614 
Genomic and mitochondrial DNA qPCR 615 
DNA was extracted using the DNeasy Blood & Tissue Kit (Qiagen). 20ng of total DNA was used in a 616 
qPCR reaction containing QuantiNova SYBR Green mix (Qiagen), which was ran on a StepOnePlus 617 
Real-Time platform (Thermo Fisher Scientific) running StepOne Software (version 2.3). To quantify 618 
gDNA the geometric mean of two primer pairs amplifying different genomic loci was used. The 619 
geometric mean of two separate mitochondrial loci was used to quantify the mtDNA. The number of 620 
functional Zbtb11lox alleles remaining in the cell population after KO induction was quantified using 621 
an intron 3-specific primer and a primer that specifically recognises the intron 3 loxP site but not the 622 
intron 2 loxP site. Cre-mediated recombination disrupts the binding site of the loxP-specific primer 623 
and therefore qPCR signal is no longer generated from the KO alleles. The signal for functional 624 
Zbtb11lox alleles was normalised to the geometric mean of the two gDNA primer pairs. 625 
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qRT-PCR  626 
RNA was extracted using the RNeasy Mini kit (Qiagen). Exogenous ERCC RNA Spike-In Mix 1 627 
(Thermo Fisher Scientific) was added at the cell lysis stage in a ratio of 1μl per 9 million cells. 1μg 628 
total RNA was used to synthesise cDNA with the ProtoScript II kit (New England Biolabs) using 629 
random primers in a 20μl reaction. The RT-PCR reaction was diluted to 100μl with ultrapure water 630 
after which 1μl was used as template in a qPCR reaction. Because initially it was not known whether 631 
Zbtb11 depletion affects the expression of housekeeping genes, gene expression in Fig. 3b was 632 
normalised to the RNA spike-in mix using primers for ERCC 002 and ERCC 003. Following the whole 633 
transcriptome analyses at 48 and 72 hours post-Zbtb11 KO induction, four suitable internal controls 634 
were identified (Hectd1, Actb, Sel1, March7) that consistently remained unchanged between replicates 635 
and data sets, and which were subsequently used for normalisation in Fig. 3c and 5F. 636 
Immunoblotting 637 
Whole cell lysates were prepared by heating 1 million cells at 95ºC in 100μl 1x Laemmli Buffer for 5 638 
minutes. For immunoblots including Mtco1, lysates were prepared in 1x Laemmli Buffer supplemented 639 
with Complete protease inhibitors (Roche) by heating at 37ºC for 5 minutes, sonicating 30 seconds in 640 
a Bioruptor Pico (Diagenode), followed by 5 more minutes of heating at 37ºC. Following separation 641 
by SDS-PAGE, proteins were transferred onto PVDF membranes, which were subsequently blocked 642 
with 5% skimmed milk in [TBS, 0.1% Tween-20]. Primary antibodies were used at a concentration of 643 
1 μg/ml: FLAG M2 (F3165, Sigma), Patz1 (sc-292109, Santa Cruz), Lamin B (sc-6216, Santa Cruz), 644 
Mrpl48 (14677-1-AP, Proteintech), Ndufc2 (15573-1-AP, Proteintech), Ndufb11 (ab183716, Abcam), 645 
Ndufa9 (ab14713, Abcam), Patz1 (sc-292109, Santa Cruz). Mtco1, Ndufb8, Sdhb, Uqcrc2, and Atp5a 646 
are part of an OXPHOS antibody cocktail (ab110413, Abcam). Because Mtco1 detection is not as 647 
efficient as the rest of the proteins detected with the antibody cocktail (Jha et al. 2016), the membranes 648 
were incubated with additional Mtco1 antibody (ab14705, Abcam). Secondary antibodies were HRP-649 
coupled: anti-mouse (P026002-2, Dako), anti-rabbit (A16029, Thermo Fisher Scientific), anti-goat 650 
(SAB3700285, Sigma). Chemiluminescence substrates used were WesternSure ECL (926-80100, LI-651 
COR) and SuperSignal West Femto (34094, Fisher Scientific).  652 
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Apoptosis measurement 653 
For intracellular staining of cleaved Caspase-3, cells were fixed in 2% formaldehyde, permeabilised in 654 
90% Methanol, and stored at -20oC. Following rehydration and blocking in PBS containing 0.5% (w/v) 655 
BSA, cells were stained for 30 minutes at room temperature with Alexa Fluor 647-conjugated anti-656 
cleaved Caspase-3 (9602, Cell Signaling Technology) and analysed by flow cytometry. The positive 657 
control sample was a 1:1 mixture of cells maintained under normal culture conditions and cells heat-658 
shocked at 45oC for 30 minutes, followed by 3 hour recovery at 37oC. For detection of 659 
phosphatidylserine externalisation, cells were stained with CF647-coupled Annexin V (4300-0325, 660 
Millipore) without fixation, at 37oC. 661 
ChIP 662 
Cultured cells were fixed in media containing 1% formaldehyde (Sigma) for 10 minutes at room 663 
temperature. CD4+ CD8+ double positive thymocytes were FACS-sorted from dissected thymi of 6 664 
weeks-old mice and fixed in DMEM containing 10% FCS and 1% formaldehyde, for 10 minutes at 665 
room temperature. Following fixation, cells were resuspended in [10 mM HEPES pH 7.5,10 mM 666 
EDTA, 0.5 mM EGTA, 0.75% Triton X-100, Complete protease inhibitors] and incubated mixing end 667 
over end for 10 minutes at 4oC. Nuclei were pelleted by centrifugation, then resuspended and incubated 668 
as before in [10 mM HEPES pH 7.5, 200 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, Complete protease 669 
inhibtors]. Subsequently nuclei were resuspended in sonication buffer [150 mM NaCl, 25 mM Tris pH 670 
7.5, 5 mM EDTA, 1% Triton X-100, 0.1% SDS, 0.5% Sodium Deoxycholate, Complete protease 671 
inhibitors (Roche)], incubated for 30 minutes on ice, and sonicated in a Bioruptor Pico (Diagenode) 672 
for 10 cycles (30 seconds on, 30 seconds off). Insoluble chromatin was pelleted by high-speed 673 
centrifugation and the supernatant was incubated with the ChIP antibody over night mixing end over 674 
end at 4oC. 1μg antibody was used per million sonicated ESCs. Antibodies used were: FLAG M2 675 
(F3165, Sigma) and Zbtb11 (NBP1-80327, Bio-Techne). Following over night incubation, 676 
antibody/chromatin complexes were pulled down by mixing 3 hours at 4oC with protein G Dynabeads 677 
(Thermo Fihser Scientific) using 5μl beads per μg antibody. Beads were washed 3 times and the DNA 678 
was eluted by shaking the beads over night at 65oC in [1xTE, 1% SDS, 0.5mg/ml proteinase K 679 
(Sigma)]. Eluted DNA was isolated by phenol/chloroform extraction and ethanol precipitation. Purified 680 
DNA was quantified using the Quant-iT PicoGreen kit (Thermo Fisher Scientific).  681 
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ChIP-reChIP 682 
Sonicated chromatin lysates were obtained as described above (see Methods: ChIP) and the protein 683 
content was measured using the Bio-Rad RC DC protein measurement kit (cat. no. 5000121). 500μg 684 
chromatin was mixed with 5μg anti-Zbtb11 antibody over night. Antibody/chromatin complexes were 685 
pulled down with 25μl protein G Dynabeads by mixing for 3 hours at 4oC. The beads were washed 686 
three times and the immunoprecipitated chromatin was eluted with 50μl [1xTE, 10mM DTT] by 687 
shaking 30 minutes at 37oC. Eluted chromatin was diluted 1:20 with [150 mM NaCl, 25 mM Tris pH 688 
7.5, 5 mM EDTA, 1% Triton X-100, 0.5% Sodium Deoxycholate, Complete protease inhibitors 689 
(Roche)], and mixed over night with with [8μg anti-GABPa antibody (Santa Cruz, sc-28312 X) pre-690 
captured on 100μl sheep anti-mouse IgG Dynabeads (by mixing 3 hours at 4oC)]. Beads were washed 691 
three times and DNA was eluted over night with 230μl [1xTE, 1% SDS, 1mg/ml proteinase K, 692 
0.3mg/ml RNase A] shaking at 65oC. DNA was extracted using a Qiagen PCR purification kit, and 693 
1/40 was used in each qPCR reaction. 694 
ChIP-seq 695 
Libraries were prepared from 10ng ChIP DNA using the NEBNext Ultra II DNA Library Prep kit for 696 
Illumina (E7645, New England Biolabs). 3 biological replicates were obtained for FLAG-Zbtb11 697 
ChIP-seq in Zbtb11FLAG/FLAG E14 cells, and 4 biological replicates for Zbtb11 ChIP-seq in Zbtb11wt 698 
E14 cells. 50 bases single read sequencing was performed on the Illumina HiSeq 2500 system, 699 
obtaining a minimum of 30 million reads for each library. Reads were trimmed and filtered using 700 
Cutadapt (Martin 2011) applying a Phred quality threshold of 25 and a minimal read length of 25 bases. 701 
Filtered reads were aligned to the mouse genome (NCBI37/mm9 assembly) with Bowtie 1.1.2 702 
(Langmead et al. 2009) keeping only uniquely aligned reads while allowing a maximum of 2 703 
mismatches. PCR/optical duplicates were removed with Picard (version 2.6.0) and peaks were called 704 
using MACS2 (Zhang et al. 2008). MACS2 was used as peak caller within the Irreproducibility 705 
Discovery Rate (IDR) pipeline (Li et al. 2011) as implemented by the ENCODE consortium. The final 706 
set of peaks was considered the conservative set for IDR <0.02. From this set we also removed 707 
blacklisted sites (Carroll et al. 2014). Overlap with UCSC gene annotations and statistical analyses 708 
were carried out in R using the Bioconductor packages GenomicRanges (version 1.36.1) and 709 
GenomicFeatures (version 1.36.4) (Lawrence et al. 2013), considering promoter regions as 2kb 710 
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upstream and 500bp downstream of transcription start sites. Normalised read coverage values for 711 
consensus peaks were obtained using the DiffBind Bioconductor package (version 2.12.0) (Stark and 712 
Brown, 2011).  713 
Motif analyses 714 
ChIP-seq peaks were centred around the summit and re-sized to 300 bases. Gene promoters were 715 
limited to the region -500 to +500 around the TSS. DNA sequences were obtained using the 716 
Bioconductor package BSgenome (version 1.52.0). De novo motif search motif matching were 717 
performed using the MEME Suite 41. 718 
RNA-seq 719 
1μg total RNA was used as starting material for each library. rRNA was depleted using the NEBNext 720 
rRNA Depletion Kit (E6310, New England Biolabs) and subsequently directional RNA-seq libraries 721 
were prepared using the NEBNext Ultra Directional RNA Library Prep Kit for Illumina (E7420, New 722 
England Biolabs). 75 bases paired end sequencing was performed on the Illumina HiSeq 2500 system, 723 
obtaining a minimum of 31 million reads for each library. Adaptor sequences and bases with a Phred 724 
quality score lower than 25 were trimmed from read ends with TrimGalore (Martin 2011), and polyA 725 
tails were removed using PRINSEQ 42. Filtered reads were aligned to the mouse transcriptome with 726 
STAR 43 using 2-pass mapping, and gene-level counts were generated with HTSeq 44. Differential gene 727 
expression (DGE) analyses were performed using the Bioconductor package edgeR (generalised linear 728 
model approach, quasi-likelihood F-test) 45.  729 
DGE analysis. Libraries were prepared from three biological replicates for each of the three sample 730 
groups. When all three replicates were used to compare  4OHT- to EtOH-treated Zbtb11lox/lox R26ERt2-731 
Cre cells, 110 genes were identified as differentially expressed (DE) (FDR < 0.05), 103 of which were 732 
down-regulated. Multi-dimensional scaling (MDS) analysis revealed that 2 of the 3 biological 733 
replicates were more similar to one another than the remaining third replicate (Supplementary Fig. 8a). 734 
The fact that this was observed for all sample groups in the same replicate, suggested these differences 735 
may be underpinned by technical variability. Removing the distant replicate decreased the dispersion 736 
across the entire gene expression range and the common biological coefficient of variation (BCV) value 737 
dropped from 17.2% to 6.7% (Supplementary Fig. 8b). Repeating the DGE analysis without the distant 738 
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replicate, 109 of the 110 DE genes found with the 3 replicates were detected, plus an additional 45 DE 739 
genes, 43 of which were down-regulated (FDR < 0.05). The effect size at these additional DE genes 740 
was smaller (median absolute fold-change 1.84 vs 2.92, p = 1.063e-13, Supplementary Fig. 8c), which 741 
is why they were only detected when the BCV is reduced. However, 44 of these genes were found to 742 
have very strong Zbtb11 binding sites at their promoters with enrichment values indistinguishable from 743 
the binding sites found at the promoters of the DE genes originally detected (p-value = 0.974, see 744 
Supplementary Fig. 8d). This suggested that the additional DE genes identified were indeed genuine 745 
Zbtb11 targets. Moreover, functional annotation term enrichment analysis with either the restricted 746 
(110) or extended (154) list of DE genes gave the same result, the cluster of terms related to 747 
mitochondria being the only significant result (FDR < 0.05), with similar enrichment scores of 6.28 748 
and 6.12, respectively. This indicated that although the extended list of DE genes contained 40% more 749 
genes, the additional ones were associated with the same functional annotation terms, among which 750 
terms related to mitochondria are enriched. We therefore considered the total of 154 DE genes to be 751 
the final list of deregulated genes 48 hours post-KO induction (Table S1).  752 
Pathway mapping and functional enrichment analysis 753 
The Database for Annotation, Visualization and Integrated Discovery (DAVID) 46,47 was used to obtain 754 
enriched annotation terms in comparison to the complete list of mouse genes 755 
(https://david.ncifcrf.gov/). Pathway mapping was carried out using the Reactome database (version 756 
65) (https://reactome.org/). 757 
TMRE staining 758 
Cells were trypsinised from maintenance cultures and aliquoted in 12-well plates at 0.5 million cells 759 
per well in 0.5ml media. A serial dilution of FCCP was prepared in media containing 400nM TMRE 760 
(2x), and 0.5ml of these dilutions was added to the cell suspension for a final concentration of 200nM 761 
TMRE and 0, 1, 2, 4, and 8μM FCCP. Cells were returned to the incubator for 20 minutes, after which 762 
they were pelleted by low speed centrifugation, washed once and resuspended in [PBS, 2% FBS] for 763 
FACS analysis.  764 
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Seahorse assay 765 
Seahorse assay plates were coated with 0.2% gelatin and dried over night in the cell culture incubator. 766 
100,000 cells were plated in each well the same day of the assay and allowed to attach for 5 hours in 767 
growth media in the presence of 5μM ROCK inhibitor (13624, Cell Signaling Technology). 768 
Subsequently growth media was replaced with Seahorse base media (102353-100, Agilent) containing 769 
2mM sodium pyruvate and 10mM glucose, and plates were incubated for an hour at 37oC and 770 
atmospheric CO2 concentration. The Seahorse MitoStress kit (103015-100, Agilent) was used to 771 
prepare dilutions of the mitochondrial inhibitors which had the following final concentrations: 1μM 772 
oligomycin, 0.5μM FCCP, 0.5μM rotenone and antimycin A. Oxygen consumption was measured 773 
using a Seahorse XF24 Analyzer with the following program: mix 4 minutes, delay 2 minutes, measure 774 
3 minutes.  775 
Normalisation. Control and Zbtb11 KO cells from each biological replicate were always assayed on 776 
the same plate. For normalisation between wells on the same plate, the amount of gDNA was used as 777 
a proxy for cell number. At the end of the Seahorse assay, media was replaced with 200μl cell lysis 778 
buffer (25mM Tris pH 7.5, 150mM NaCl, 5mM EDTA, 1% Triton X-100, 0.2% SDS, 0.5% 779 
Deoxycholate, 0.25mg/ml proteinase K), plates were sealed with adhesive film and incubated over 780 
night at 37oC. Plates were briefly centrifuged, and lysates were homogenised by pipetting, followed by 781 
1:10 dilution with ultra pure water. Diluted lysates were transferred to PCR plates and sealed. 782 
Proteinase K was inactivated by incubating the diluted lysates at 95oC for 15 minutes, after which 2μl 783 
were used in a qPCR reaction. The mean qPCR signal from two different genomic primer pairs (see 784 
Supplemental Information for primer sequences) was used to obtain a size factor for each well.  785 
To average oxygen consumption rates (OCR) from all biological replicates, an additional plate-wide 786 
adjustment factor was applied. This was calculated based on the expectation that overall, control cells 787 
on different plates should have similar maximal OCR after correcting for cell number. Following 788 
normalisation to gDNA, maximal respiration values were averaged across all control samples, and 789 
subsequently used to calculate an adjustment factor relative to the inter-replicate mean.  790 
Parameter calculation. Following normalisation, mitochondrial respiration parameters were 791 
calculated as defined previously 24: non-mitochondrial respiration (respiration detected after complete 792 
inhibition of mitochondrial respiration with rotenone and antimycin A); basal respiration (respiration 793 
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measured before the addition of any mitochondrial poisons, minus non-mitochondrial respiration); leak 794 
respiration (respiration measured after inhibition of ATP synthase with oligomycin, minus non-795 
mitochondrial respiration); ATP production (basal respiration minus leak and non-mitochondrial 796 
respiration); maximal respiration (the maximal respiration measured after treating cells with a pre-797 
determined optimal FCCP amount (0.5μM), minus non-mitochondrial respiration); spare capacity 798 
(maximal respiration minus basal respiration); coupling efficiency (ATP production as fraction of basal 799 
respiration). Statistical tests were performed using the R package stats. 800 
Mitochondria Isolation 801 
Mitochondria were isolated as described 48. 25 million cells were lysed in 1ml hypotonic buffer (5mM 802 
MOPS pH 7.25, 180mM KCl, 1mM EDTA, EDTA-free protease inhibitors) using a Dounce 803 
homogeniser. Nuclei and debris were removed by centrifugation at 1,000xg, and the supernatant was 804 
subsequently centrifuged at 10,000xg to pellet mitochondria. Mitochondria were resuspended in the 805 
same hypotonic buffer, and following total protein measurement, 50μg aliquots were pelleted by 806 
centrifugation at 10,000xg and snap-frozen.   807 
Blue Native Polyacrylamide Gel Electrophoresis (BN-PAGE) 808 
50μg mitochondria were solubilised in [10mM bis-Tris pH 7.0, 50mM 6-aminohexanoic acid, 2% 809 
digitonin] and incubated 20 minutes on ice. Insoluble material was removed by centrifugation and 810 
Comassie Brilliant Blue G-250 was added to a final concentration of 0.6%. Gel and electrophoresis 811 
buffers used have been previously described 49. Native complexes were separated for 30 minutes at 812 
150V using blue cathode buffer (15mM bis-Tris pH 7.0, 50mM tricine, 0.02% (w/v) Comassie Brilliant 813 
Blue G-250), after which the blue cathode buffer was replaced with clear cathode buffer (15mM bis-814 
Tris pH 7.0, 50mM tricine) and complexes were further separated for 2.5 hours at 250V. Following 815 
BN-PAGE, native gels were equilibrated in transfer buffer (48mM Tris, 39mM Glycine, 0.03% SDS, 816 
20% Methanol) for 10 minutes and  subsequently transferred onto PVDF membrane for 1.5 hours at 817 
350mA using a wet transfer system. Blocking and detection was performed as described above. 818 
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Spectrophotometric measurements of complex I 819 
50μg mitochondria were solubilised in [10mM bis-Tris pH 7.0, 2% digitonin] and incubated 20 minutes 820 
on ice. 25μg mitochondrial extract was aliquoted in each well of a microtiter plate, and subsequently 821 
200μl complex I substrate solution [2mM Tris-HCl pH 7.4, 0.1mg/ml NADH, 2.5mg/ml nitro blue 822 
tetrazolium chloride] was added to all wells simultaneously with a multichannel pipette, followed by 823 
mixing and incubation at room temperature for 2 minutes. The activity of complex I was quantified by 824 
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Figure Legends 998 
 999 
Fig. 1. Zbtb11 is enriched at promoters of nuclear-encoded mitochondrial genes 1000 
(a) CRISPR/Cas9 'knock-in' approach used to generate the Zbtb11FLAG allele. Two gRNAs targeting 1001 
the 5’ end of the coding region in the Zbtb11 gene were used in combination with the Cas9 nickase, 1002 
and a donor template for homology-directed repair (HDR). The donor template contained the 3xFLAG 1003 
tag immediately downstream of the translation initiating methionine and was protected from Cas9 1004 
activity through the substitution of poorly conserved non-coding nucleotides at the gRNA2 site (*), 1005 
and because the gRNA1 site is disrupted by the 3xFLAG insertion.  1006 
(b) Anti-FLAG immunoblot of whole cell lysates from a Zbtb11FLAG/FLAG homozygous cell line, and 1007 
the parental line E14 (Zbtb11WT/WT). Patz1 was used as loading control. Molecular weight marker unit 1008 
is KDa. Source data are provided as a Source Data file. 1009 
(c) Overlap between ChIP-seq peaks for FLAG ChIP in Zbtb11FLAG/FLAG E14 cells, and for ChIP with 1010 
anti-Zbtb11 antibodies in the parental line E14 (see also Supplementary Fig.1c and 1d). 1011 
(d) Example of read coverage at a Zbtb11 target locus (Mrpl48). FLAG ChIP in E14 WT (FLAG 1012 
control) is shown as background control (see also Supplementary Fig.1c and 1d). 1013 
(e) Genome-wide distribution of Zbtb11 peaks with respect to gene features. The distribution of the 1014 
entire Zbtb11 ChIP-seq dataset is shown alongside that of Zbtb11-high peaks. Within the fraction of 1015 
peaks found at the promoters, the hatched area indicates the proportion found at CpG island promoters. 1016 
Source data are provided as a Source Data file. 1017 
(f) DAVID functional annotation terms associated with genes that have Zbtb11-high peaks present at 1018 
their promoters (FDR < 0.05). Plot shows enrichment values vs significance (-log10FDR) when 1019 
compared to all genes in the mouse genome. Source data are provided as a Source Data file. 1020 
(g) Venn diagram: conservation of Zbtb11-high peaks at promoters in mESCs, mouse thymocytes and 1021 
HEK293. The p-value for each pairwise hypergeometric test was p < 2.2e-16. Box plots: distribution 1022 
of Zbtb11 ChIP-seq signal at conserved and cell type/species-specific peaks, showing that Zbtb11 1023 
preferentially binds to conserved peaks. P-values are for Wilcoxon rank sum tests. Box plots show the 1024 
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interquartile range (box outline) and median value (horizontal line), with the whiskers delineating the 1025 
lower and upper limits of the data. Source data are provided as a Source Data file. 1026 
 1027 
(h) Conservation of Zbtb11 binding preference at target promoters, across tissues (left panel, mouse 1028 
ESCs vs thymocytes) and species (right panels, mESCs vs human HEK293 cells, and mouse 1029 
thymocytes vs HEK293). Pearson correlation coefficients (r) and p-values (p) for two-sided correlation 1030 
tests are shown. Source data are provided as a Source Data file. 1031 
 1032 
Fig. 2. Zbtb11 is essential for proliferation and cell viability 1033 
(a) CRISPR 'knock-in' strategies used to generate the conditional Zbtb11 KO allele (Zbtb11lox) (left), 1034 
and to insert the ERt2-Cre transgene in the Rosa26 locus (right). The loxP sites (lox) flanking Zbtb11 1035 
exon 3 include ectopic restriction sites (see Supplementary Fig.2a). Red arrow heads mark qPCR 1036 
primers used to measure the deletion efficiency once ERt2-Cre is activated - recombination between 1037 
the two loxP sites leads to excision of the left primer binding site along with exon 3 so PCR products 1038 
are no longer generated. 1039 
(b) Time-course experiment describing the dynamics of Zbtb11 inactivation in our inducible Zbtb11 1040 
KO ESC line (Zbtb11lox/lox Rosa26ERt2-Cre). Upper panel - decay of functional Zbtb11 alleles (red circles, 1041 
n=6 independent experiments, except 24h timepoint for which n=3), Zbtb11 transcripts (grey 1042 
diamonds, n=3) and protein (blue triangles, n=3) in 4OHT-treated cells relative to their EtOH-treated 1043 
control cells following KO induction. Lower panel - growth curves, with p-values (two-tailed paired t-1044 
test) above each timepoint. Source data are provided as a Source Data file. 1045 
(c) Propidium iodide stain for cell cycle analysis of control (Zbtb11lox/lox EtOH) and Zbtb11 KO 1046 
(Zbtb11lox/lox 4OHT) cells. 4OHT-treated Zbtb11wt/wt cells were included to control for potential non-1047 
specific effects of 4OHT. Top two panels - representative flow cytometry histograms showing the 1048 
distribution of DNA content in the sampled cell populations. G1, S or G2/M phases of the cell cycle 1049 
are indicated on the horizontal axis. Bottom panel - mean and SD of the fractions of 4OHT-treated 1050 
cells present in each cell cycle phase (normalised to EtOH-treated controls, n = 2). Source data are 1051 
provided as a Source Data file. 1052 
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(d) Bright field microscopy images of 144 hours Zbtb11 KO and control cells, illustrating the collapse 1053 
of the culture 6 days after inducing Zbtb11 KO. 1054 
(e) Quantification of cell death after Zbtb11 KO induction with FITC-coupled Annexin V. The fraction 1055 
of Annexin V-positive cells is shown for n=3 (48h), n=5 (72h, 96h and 120h) independent experiments 1056 
(see also Supplementary Fig.2d and Supplementary Figure 9). P-values (two-tailed t-test) are shown 1057 
above. Source data are provided as a Source Data file. 1058 
 1059 
Fig. 3. Zbtb11 supports the expression of a subset of nuclear encoded mitochondrial proteins 1060 
(a) Whole-transcriptome analysis by RNA-seq comparing Zbtb11lox/lox Rosa26ERt2-Cre cells treated with 1061 
either EtOH (Control) or 4OHT (Zbtb11 KO) for 48 hours. Plot shows log2-transformed fold-change 1062 
(logFC) against transcript abundance (mean counts per million, logCPM) for all genes expressed in 1063 
ESCs. Differentially expressed (DE) genes (FDR < 0.05) are shown in red. 1064 
(b) Zbtb11 expression rescue experiment. Zbtb11lox/lox Rosa26ERt2-Cre cells were transfected with a 1065 
plasmid expressing either FLAG-Zbtb11–IRES–GFP, or GFP alone as control, and treated with either 1066 
EtOH (Control) or 4OHT (Zbtb11 KO). GFP-positive cells were FACS-sorted 48 hours post-treatment. 1067 
Left panel - immunoblot of whole-cell lysates showing the expression of Zbtb11 protein was 1068 
specifically restored. Right panel - qRT-PCR measuring the expression of a panel of genes down-1069 
regulated in Zbtb11 KO cells. Barplot shows mean and standard deviation of n=5 independent 1070 
experiments. Source data are provided as a Source Data file. 1071 
(c) Conservation of Zbtb11 binding at promoters of Zbtb11-dependent genes. Plots show strength of 1072 
Zbtb11 binding at conserved target promoters in mESC, thymocytes and HEK293 cells (see also Fig. 1073 
1f). Binding sites at promoters of genes DE in Zbtb11 KO cells are marked in red - note these are the 1074 
strongest sites in the dataset and very well conserved across cell types and species. r = Pearson 1075 
correlation coefficient; p = p-value for two-sided correlation test based on Pearson’s product moment 1076 
correlation coefficient. 1077 
(d) DAVID functional annotation analysis of the genes differentially expressed in Zbtb11 KO indicates 1078 
one significant cluster of annotation terms (FDR < 0.05), which is related to mitochondria. Significance 1079 
(-log10FDR) is plotted against enrichment of the annotation terms associated with the genes. 1080 
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(e) Immunoblots for two mitochondrial proteins (Mrpl48 and Ndufc2) for which transcripts were found 1081 
to be down-regulated in Zbtb11 KO cells. LaminB was used as loading control. 1082 
 1083 
Fig. 4. Zbtb11 controls the locus-specific recruitment of NRF-2 1084 
(a) Zbtb11 top motifs identified de novo from Zbtb11-high peaks in mESCs and HEK293 cells, 1085 
respectively (MEME-ChIP E-values indicated), aligned to previously determined GABPa motif (upper 1086 
panel). FDR for the Zbtb11 motif match to GABPa is indicated above. 1087 
(b) Top motifs identified de novo from the promoter sequences of Zbtb11-dependent genes in mouse 1088 
(mESC) and human (HEK293), respectively. Lower panel - the probability distribution for GABPa and 1089 
NRF-1 motifs in the promoter regions of Zbtb11-dependent genes. Enrichment p-values are given for 1090 
each motif. 1091 
(c) Genome-wide overlap between ChIP-seq peaks identified in mouse ES cell for Zbtb11, NRF-1 and 1092 
GABPa. P-values for pairwise hypergeometric tests (see Methods) are shown in the table. 1093 
(d) Correlation ChIP-seq signal (normalised read coverage) at overlapping peaks. Peaks at promoters 1094 
of Zbtb11-dependent genes are circled in red. 1095 
(e) Zbtb11, NRF-1 and GABPa ChIP-seq signal (quantiles of normalised read coverage) at the 1096 
promoters of all genes expressed in mouse ESCs (left panels, n = 14,362), and at the promoters of 1097 
Zbtb11-dependent genes (right panels, n = 154). 1098 
(f) Sequential ChIP enrichment values at a panel of Zbtb11-dependent and -independent promoters in 1099 
wild type mouse ESCs, using the indicated combinations of ChIP and reChIP antibodies (mean and SD 1100 
of three replicates). Source data are provided as a Source Data file. 1101 
(g) GABPa and NRF-1 ChIP enrichment values at a panel of Zbtb11-dependent and -independent 1102 
promoters, in control and Zbtb11 KO cells. Bars represent means and standard deviations of n=3 1103 
(GABPa) and n=4 (NRF-1) independent experiments (shown as open circles). P-values for two-tailed 1104 
t-tests comparing control to Zbtb11 KO samples are shown above each binding site. Source data are 1105 
provided as a Source Data file. 1106 
 1107 
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Fig. 5. Zbtb11 depletion results in impaired mitochondrial respiration 1108 
(a) Changes in mitochondrial membrane potential (MMP) caused by Zbtb11 depletion. Control and 1109 
Zbtb11 KO cells were stained with TMRE (Tetramethylrhodamine, ethyl ester) at the indicated time 1110 
following KO induction. Mean fluorescence intensity obtained by flow cytometry and their means are 1111 
shown in samples without (left) and with 4uM FCCP (right). Individual data points and means are 1112 
shown for n=6 (no FCCP) and n=5 (FCCP-treated) independent experiments, respectively. P-values 1113 
for paired two-tailed t-tests are shown above. See also Supplementary Fig. 5b for full FCCP titration 1114 
curves. 1115 
(b) Decreased mitochondrial respiration in Zbtb11 KO cells. Zbtb11lox/lox Rosa26ERt2-Cre cells were 1116 
treated with either EtOH or 4OHT for 48 or 72 hours, and oxygen consumption rates (OCR) were 1117 
measured using the Seahorse platform before and after the sequential addition of the ATP synthase 1118 
inhibitor oligomycin (O), the mitochondrial uncoupler FCCP, and a mix of rotenone (complex I 1119 
inhibitor) and antimycin A (complex III inhibitor) (Rot/AA). Upper panels - OCR values adjusted for 1120 
gDNA content (measured by qPCR and used as a proxy for cell number), showing mean ± SEM of 8 1121 
(48h) and 7 (72h) biological replicates, and a total of 44-48 measurements (technical x biological). 1122 
Lower panels – mitochondrial respiration parameters (mean ± SD) in control and Zbtb11 KO cells, 1123 
calculated from OCR measurements (see Methods). P-values (Wilcoxon rank sum test) are indicated 1124 
above each pair.  1125 
 1126 
Fig. 6. Zbtb11 controls assembly and stability of respiratory complex I 1127 
(a) Differentially expressed genes mapping to enriched mitochondrial pathways (see also 1128 
downregulation of Ndufc2 at protein level in Fig. 3e). 1129 
(b) Immunoblots of whole cell lysates from control and Zbtb11 KO cells, probing stability markers of 1130 
all five OXPHOS complexes. Molecular weight marker unit is KDa. Note that none of the stability 1131 
markers probed in the blot are affected at the transcriptional level by Zbtb11 depletion; the down-1132 
regulation of Ndufb8 is a consequence of complex I instability caused by down-regulation of other 1133 
complex I subunits that are under direct Zbtb11 control, as listed in Fig. 6a (see also Fig. 3e). Source 1134 
data are provided as a Source Data file. 1135 
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(c) SDS-PAGE and immunobloting of complex I subunits in whole cell lysates of control and Zbtb11 1136 
KO cells showing that not all complex I subunits are down-regulated. Lamin B is shown as loading 1137 
control. Source data are provided as a Source Data file. 1138 
(d) Immunoblot of native mitochondrial extracts separated by BN-PAGE. Complex I was detected with 1139 
antibodies to the Ndufb11 subunit (which was not affected by Zbtb11 depletion, see Fig. 6c). Note the 1140 
reduction in complex I holocomplexes (*) and supercomplexes (**), and the increase in a smaller 1141 
Ndufb11-containing assembly intermediate (***). Complex V detected with anti-Atp5a antibodies is 1142 
shown as loading reference. Molecular weight marker unit is KDa. Source data are provided as a Source 1143 
Data file. 1144 
(e) Spectrophotometric quantification of complex I activity in mitochondrial extracts from control and 1145 
Zbtb11 KO cells. Individual data points and means are shown for n=3 (48h), n=4 (72h and 96h) and 1146 
n=2 (120h) independent experiments. 1147 
(f) Rates of cell proliferation in control and Zbtb11 KO cells grown in standard ES media (Std ES), 1148 
and in media supplemented with supraphysiological amounts of pyruvate (Pyr) or aspartate (Asp). Bars 1149 
represent mean and standard deviation of n=5 (72h) and n=4 (96h) independent experiments (shown 1150 
as open circles). Source data are provided as a Source Data file. 1151 
 1152 
Fig. 7. Zbtb11 is required for the biogenesis of respiratory complexes I, III, and IV 1153 
(a) SDS-PAGE and immunoblotting of whole cell extracts following inhibition of mitochondrial 1154 
translation with chloramphenicol. Samples from cells treated with ethanol (carrier) were used as 1155 
reference. Note that complexes I, III and IV are sensitive to the mitochondrial translation block. Lamin 1156 
B is shown as loading control. Molecular weight marker unit is KDa. Source data are provided as a 1157 
Source Data file. 1158 
(b) Diagram of the experimental design used to compare de novo synthesis of respiratory complexes 1159 
in control and Zbtb11 KO cells. Fully assembled complexes I, III and IV were depleted from 1160 
Zbtb11lox/lox Rosa26ERt2-Cre cells by inhibiting mitochondrial translation for 48 hours (as in Fig. 7a). 1161 
Mitochondrial translation was then allowed to resume by removing the chloramphenicol treatment, and 1162 
samples for immunoblotting were collected at 24 hour intervals in order to monitor the regeneration of 1163 
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respiratory complexes. The chloramphenicol treatment was synchronised with the addition of 4OHT 1164 
(or EtOH as control), so that translation was allowed to resume either 48 hours (experiment version 1) 1165 
or 72 hours (experiment version 2) post-Zbtb11 KO induction, thus allowing to compare de novo 1166 
synthesis of respiratory complexes in control and Zbtb11 KO cells. 1167 
(c) Immunoblotting analyses of representative experiments comparing de novo synthesis of respiratory 1168 
complexes I, III and IV, in control and Zbtb11 KO cells, as outlined in Fig. 7b. Molecular weight 1169 
marker unit is KDa. Note that the synthesis of complexes III and IV is only partly impaired in Zbtb11 1170 
KO cells, while the synthesis of complex I is completely blocked. Source data are provided as a Source 1171 
Data file. 1172 
 1173 
Fig. 8. Mutations associated with intellectual disability destabilise the Zbtb11 protein and impair 1174 
complex I biogenesis 1175 
(a) qPCR quantification of transcripts in control and Zbtb11 KO cells rescued with either wild type 1176 
(WT) or mutant Zbtb11 cDNA. Zbtb11lox/lox Rosa26ERt2-Cre cells were treated with either EtOH 1177 
(Control) or 4OHT (Zbtb11 KO), and concomitantly transfected with a plasmid expressing either WT 1178 
or the indicated mutant FLAG-Zbtb11 cDNA fused to an IRES-GFP reporter. 48 hours later 1179 
successfully transfected cells were sorted based on GFP expression, gating on cells with intermediate 1180 
fluorescence, thus selecting cells expected to have similar levels of cDNA expression. Bars represent 1181 
mean and standard deviation. Source data are provided as a Source Data file. 1182 
(b) Immunoblot of whole cell lysates of Zbtb11 KO cells rescued with either WT or mutant Zbtb11 1183 
cDNA. Cells treated and sorted as in (a), except collected 72 hours post-Zbtb11 KO induction, were 1184 
analysed by immunoblotting for the complex I stability marker (Ndufb8) and FLAG-Zbtb11 1185 
expression. Lamin B was used as loading reference. Left panel shows a representative image of the 1186 
results, while the two panels on the right show the quantification of the blots from 3 biological 1187 
replicates. Source data are provided as a Source Data file. 1188 
(c) Correlation of expression between Zbtb11 and its target genes in primary human tissues. Box plot 1189 
to the left shows normalised expression of human ZBTB11 across primary tissues sampled in the GTEx 1190 
dataset. The heatmaps below represent the same tissues as in the boxplot and median expression values 1191 
for the human orthologues of Zbtb11-dependent genes (upper panel), and for an equal number of 1192 
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randomly selected genes as control (lower panel). Box plot to the right shows distribution of correlation 1193 
coefficients for expression of ZBTB11 and that of individual target genes across the GTEx tissues. p = 1194 
p-value for two-sided Wilcoxon rank sum test.  Box plots show the interquartile range (box outline) 1195 
and median value (horizontal line), with the whiskers delineating the lower and upper limits of the data. 1196 
Number of individual samples (n) in the GTEx database varies for each individual tissue, as follows: 1197 
Brain - Cerebellar Hemisphere=215; Brain - Cerebellum=241; Uterus=142; Nerve - Tibial=619; 1198 
Ovary=180; Fallopian Tube=9; Cervix - Endocervix=10; Lung=578; Spleen=241; Artery - Tibial=663; 1199 
Cervix - Ectocervix=9; Skin - Not Sun Exposed (Suprapubic)=604; Vagina=156; Testis=361; 1200 
Thyroid=653; Skin - Sun Exposed (Lower leg)=701; Artery - Coronary=240; Bladder=21; Adipose - 1201 
Subcutaneous=663; Artery - Aorta=432; Colon - Sigmoid=373; Breast - Mammary Tissue=459; 1202 
Esophagus - Mucosa=555; Small Intestine - Terminal Ileum=187; Pituitary=283; Adipose - Visceral 1203 
(Omentum)=541; Brain - Frontal Cortex (BA9)=209; Prostate=245; Esophagus - Gastroesophageal 1204 
Junction=375; Minor Salivary Gland=162; Esophagus - Muscularis=515; Brain - Spinal cord (cervical 1205 
c-1)=159; Colon - Transverse=406; Stomach=359; Adrenal Gland=258; Brain - Nucleus accumbens 1206 
(basal ganglia)=246; Kidney - Medulla=4; Brain - Cortex=255; Brain - Hypothalamus=202; Brain - 1207 
Caudate (basal ganglia)=246; Muscle - Skeletal=803; Brain - Anterior cingulate cortex (BA24)=176; 1208 
Pancreas=328; Brain - Putamen (basal ganglia)=205; Brain - Hippocampus=197; Brain - Substantia 1209 
nigra=139; Brain - Amygdala=152; Liver=226; Heart - Atrial Appendage=429; Kidney - Cortex=85; 1210 
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Supplementary Fig. 1.  
(a) Immunoblot with anti-FLAG antibodies showing specific and efficient immunoprecipitation (IP) 
of FLAG-Zbtb11 from chromatin lysates (Input) of Zbtb11FLAG/FLAG E14 cells but not from lysates 
of the wild type parental line. Molecular weight marker unit is KDa. Source data are provided as a 
Source Data file. 
(b) qPCR analysis of FLAG ChIP samples from Zbtb11FLAG/FLAG E14 cells and of anti-Zbtb11 ChIP 
from the parental wild type E14 line. Bars show mean and SD of ChIP enrichment values (as 
percentage of input) obtained from three biological replicates. The panel of primers amplify the 
promoter regions at the indicated genes. Note the similar distribution of enrichment values obtained 
with the two different approaches. Source data are provided as a Source Data file. 
(c) Correlation of Zbtb11 and FLAG-Zbtb11 ChIP-seq signal at consensus peaks. Plotted values 
represent mean normalised coverage obtained by averaging the individual biological replicates from 
each dataset. Pearson’s r is shown. 
 (d) ChIP-seq signal across part of chromosome 7 illustrating the reproducible enrichment obtained 
for both FLAG-Zbtb11 ChIP in Zbtb11FLAG/FLAG E14 cells, and Zbtb11 ChIP in the parental wild 
type E14 line. By contrast, no enrichment was generated by the control ChIP experiment using 
FLAG antibodies in the parental E14 line. 
 (e) Box plot showing the distributions of FLAG-Zbtb11 and Zbtb11 ChIP enrichment values (as 
obtained during peak calling, see Methods) at peaks that are common or unique to the two datasets. 
Note that peaks detected with only one of the two approaches are significantly weaker than the 
common peaks, which makes them more likely to be false positives. Box plots show the interquartile 
range (box outline) and median value (horizontal line), with the whiskers delineating the lower and 
upper limits of the data. 
(f) Distribution of Zbtb11 ChIP signal in mESC, mouse thymocytes and HEK293 cells. Outlier 
values (1.5x the interquartile range above the third quartile) used to designate Zbtb11-high peaks 
are shown in blue. The median of the distribution is shown by the red dashed line. 
 
(g) DAVID functional enrichment analysis of genes with Zbtb11-high peaks at their promoters in 
human HEK293 cells. Plot shows enrichment values vs significance (-log10FDR) when compared to 
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Supplementary Fig. 2 
(a) Restriction enzyme digest analysis of the Zbtb11 locus in Zbtb11lox/lox Rosa26ERt2-Cre ESC line. 
Successful insertion of the two loxP sites flanking exon 3 introduces an ectopic EcoRI site in intron 
2 and a BamHI site in intron 3. A 3.6kb region spanning intron 2, exon 3 and part of intron 3 was 
amplified from gDNA using primers outside the region of homology with the donor template (HDR). 
Lower panel - DNA agarose gel showing that the PCR amplicon from the parental wild type line is 
not digested by either EcoRI or BamHI (left), while the amplicons from the recombinant 
homozygous line are digested by both EcoRI and BamHI (right). The dotted vertical line in the lower 
panel indicates where intervening lanes have been removed from the image. The unit of the size 
marker is kb.  
(b) ChIP-qPCR with anti-Zbtb11 antibodies in Zbtb11lox/lox Rosa26ERt2-Cre cells treated with either 
EtOH (control) or 4OHT (Zbtb11 KO) (treatment duration indicated on the right). The primers 
amplify promoter regions at the indicated genes. Bars show mean and SD of three biological 
replicates. Note the complete depletion of Zbtb11 protein 48 hours after KO is induced. 
(c) Quantification of apoptotic cells following Zbtb11 KO. Zbtb11lox/lox Rosa26ERt2-Cre cells were 
treated with either EtOH or 4OHT and samples were subsequently collected and fixed at 24 hour 
intervals. Cells were then stained with fluorescently labelled antibodies to Caspase-3 and analysed 
by flow cytometry to measure the fraction of Caspase-3 positive cells. Bars show mean and SD of 
5 biological replicates, with two-tailed t-test p-values above. Note that this approach did not reveal 
an increase in apoptotic cells despite being able to specifically and efficiently detect apoptosis in a 
positive control sample made up of cells submitted to heat-shock (+). 
(d) Representative histograms showing the distribution of Annexin V-binding cells as measured by 
flow cytometry, which was used as a marker of cell death. Line interval demarcates Annexin V-
positive cells. Note that an increase in Annexin V-binding cells becomes evident 96 hours after 









Supplementary Fig. 3 
(a) Fold-change values obtained by RNA-seq for 20 genes plotted against fold-change values 
obtained by qRT-PCR for the same genes. qRT-PCR values represent mean of n=3 (Ankrd40, Hus1, 
Mrpl1, Mrpl3, Mrpl30, Mrps31, Mrpl48, Ndufc2, Slc35a3, Taco1, Trdmt1) and n=5 (Acsf3, Bbc3, 
Ict1, Mrpl13, Mrpl16, Mrpl44, Mtg1, Ndufaf1, Trp53) independent experiments. 
(b) Boxplot showing the distribution of Zbtb11 ChIP-seq signal strength among peaks found at 
promoters of DE genes, compared to Zbtb11-high peaks, and the entire peak set. Outlier values in 
the distribution of the entire Zbtb11 peak set are not shown as these make up the Zbtb11-high group 
(see also Supplementary Fig.1f). P-value (Wilcoxon rank sum test) is shown above. Box plots show 
the interquartile range (box outline) and median value (horizontal line), with the whiskers 
delineating the lower and upper limits of the data. Note that peaks found at promoters of DE genes 
are overall significantly stronger than the rest.  
(c) Correlation of transcript abundance for Zbtb11-dependent genes across different cell types and 































































































































Supplementary Fig. 4 
(a) Results of de novo motifs analyses using the sequences of Zbtb11-high ChIP-seq peaks identified 
in mouse ESCs and human HEK293 cells, respectively. 
(b) Read coverage tracks for Zbtb11, GABPa and NRF-1 ChIP-seq in WT mouse ESCs. Three 
Zbtb11-independent loci (top) and three Zbtb11-dependent loci (bottom) are shown. 
(c) ChIP-qPCR for Zbtb11, GABPa, NRF-1 and control rabbit IgG. Bars are mean and SD of 
enrichment values relative to Input detected with primers amplifying the promoter regions of the 
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Supplementary Fig. 5 
(a) qPCR quantification of mtDNA content relative to gDNA following Zbtb11 KO induction. 
Individual measurements and means are shown for n=6 (48h), n=5 (72h) and n=3 (96h) independent 
experiments.  
(b) Increased sensitivity of the MMP to mitochondrial uncoupler treatment in Zbtb11 KO cells. 
Panels to the left - control and Zbtb11 KO cells (time post-4OHT treatment indicated on the right) 
were stained with TMRE in the presence of increasing amounts of FCCP, and analysed by flow 
cytometry. Plots show TMRE mean fluorescence intensity against FCCP concentration (mean ± SD, 
n = 4-7 biological replicates). Panels to the right - to control for potential non-specific effects of the 
4OHT treatment on the MMP, the TMRE staining and FCCP titration was carried out in EtOH- and 
4OHT-treated Zbtb11wt/wt Rosa26wt cells, showing that 4OHT treatment of wild type cells does not 




















Supplementary Fig. 6  
SDS-PAGE of mitochondrial extracts from EtOH-treated (control) and 4OHT-treated (Zbtb11 KO) 
Zbtb11lox/lox Rosa26ERt2-Cre cells, followed by immunoblotting showing the mitochondria-encoded 
proteins Mtco1 and Mtco3 are down-regulated from 96 hours post-KO induction onwards. The 
nuclear-encoded complex II subunit Sdhb is shown as loading reference. Similar results were 






















Zbtb11   Cre  +4OHT (Ctrl) wt         -   
Zbtb11    Cre  +EtOH (Ctrl) lox         +   
Zbtb11    Cre  +4OHT (KO) lox         +   
Zbtb11   Cre  +4OHT (Ctrl) wt         -   
Zbtb11    Cre  +EtOH (Ctrl) lox         +   



























Zbtb11         R26             4OHT/EtOHlox/lox          ERt2-Cre























Supplementary Fig. 7 
(a) Visualisation of normalised read coverage tracks for Zbtb11 ChIP-seq in control cells, and for 
RNA-seq in control and Zbtb11 KO cells. Top panel – locus encoding p53 (Trp53) showing no 
transcriptional changes. Bottom panel - Ndufc2 locus shown for comparison, illustrating 
transcriptional down-regulation. 
(b) qRT-PCR analysis of Trp53 transcription in control and Zbtb11 KO cells, 48 and 72 hours post-

















































































p = 2.2e-06DE genes identified using all 3 replicates




Supplementary Fig. 8  
(a) Multidimensional scaling (MDS) plot of the RNA-seq libraries. 
(b) Biological coefficient of variation (BCV) plotted against transcript abundance (mean counts per 
million) when all three RNA-seq replicates are included in the analysis (left) or when replicate 1 is 
removed (right). 
(c) Plot of log2-transformed fold-change against transcript abundance obtained after removing 
RNA-seq replicate 1 from the differential gene expression analysis. In red are shown DE genes 
found by using all three replicates, while additional DE genes identified after removal of replicate 1 
are shown in blue. 
(d) Boxplot of Zbtb11 ChIP-seq signal showing that peaks at promoters of the additional DE genes 
identified once RNA-seq replicate 1 is removed are as strong as the peaks found at the DE genes 
initially identified with all three RNA-seq replicates. P-values for pair-wise comparisons of the 
distributions are shown above the plot and were obtained by performing a two-sided Wilcoxon rank 
sum test. Box plots show the interquartile range (box outline) and median value (horizontal line), 












Select R1 events 
in order to reveal 
debris




Flow cytometry gating strategy for measuring AnnexinV-positive cells in Figure 2e and 
Supplementary Figure 2d.
Supplementary Fig. 9 
Gate out doublets (gate on R3 
events)
 
Supplementary Fig. 9 
Flow cytometry gating strategy for measuring AnnexinV-positive cells in Figure 2e and 








* persistent FLAG-Zbtb11 signal after 
reprobing the blot with anti-Patz1 
  
** cross-reactivity of molecular weight 






































* cross-reactivity of anti-goat 
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Supplementary Fig. 10. Uncropped immunoblots used in the figures. 





